Vasso Apostolopoulos, PhD Professor

Email: vasso@scientist.com

     Vasso Apostolopoulos - Posters and Abstracts
Website Designed by www.SevenStarWebsites.com™  Copyright ©  2011-2014
May 2013, 4th International Congress on neuropathic pain. The pain to relief starts with understanding. Toronto, Canada
October 2013, Helani Congress of Neuroimmunology for MS. Athens, Greece
March 2011, Keystone Symposia. New Frontiers at the interface of immunity and glycobiology. Lake Louse, Alberta Canada
July 2007, 5th International Conference DC2007 - DC Vaccination. Bamberg, Germany
1992, Poster Presentation, University of Auckland, New Zealand
POSTER PRESENTATIONS


Summary Conference Poster Presentations:  Total - 133   
1st author - 31
Last author - 46 (all post 2004)
Highly Commended poster - 1
Best poster award - 2
Apostolopoulos, V., Xing, P.X., Trapani, J. and McKenzie, I.F.C. 21st Annual Scientific meeting, The Australian Society for Immunology Inc., Perth, Australia, Sept. 1991. Monoclonal antibodies reactive with mucins expressed in breast cancer

Apostolopoulos, V., Xing, P.X. and McKenzie, I.F.C. 36th Annual Conference, The Australian Society for Biochemistry and Molecular Biology Inc., Melbourne, Australia, Dec. 1992. Second generation MUC3 peptide monoclonal antibodies reactive with colon cancer

Apostolopoulos, V., Xing, P.X. and McKenzie, I.F.C. 22nd Annual Scientific meeting, The Australasian Society for Immunology Inc., Auckland, New Zealand, Dec 1992. Second generation monoclonal antibodies reactive with gastrointestinal mucin.

Apostolopoulos, V., Xing, P.X., Prenzoska, J. and McKenzie, I.F.C. 22nd Annual Scientific meeting, The Australasian Society for Immunology Inc., Auckland, New Zealand, Dec. 1992. Immunotherapy for Breast Cancer.

McKenzie, I.F.C., Apostolopoulos, V. and Xing, P.X. J. Cell. Biochem., Abstract Supplement, Taos, New Mexico, March 1993. Immunotherapy for breast cancer with synthetic peptides

Apostolopoulos, V., Xing, P.X. and McKenzie, I.F.C. Austin Hospital Research Week. Melbourne, Australia, Oct. 1993. Use of synthetic peptides to immunise against breast cancer

Apostolopoulos, V., Xing, P.X., Pietersz, G.A. and McKenzie, I.F.C. International Congress on the Regulation of Leukocyte Production and Immune Function. The Australasian Society for Immunology Inc. and International Society for Leukocyte Biology, joint meeting. Sydney, Australia, Dec. 1993
Use of synthetic peptides to immunise against breast cancer

Apostolopoulos, V., Xing, P.X., Pietersz, G.A. and McKenzie, I.F.C. 6th Lorne Cancer Conference, Lorne, Australia, Feb. 1994. Is a breast cancer vaccine feasible?

Xing, P.X., Apostolopoulos, V., Prenzoska, J., Wreschner, D. and McKenzie, I.F.C. 6th Lorne Cancer Conference, Lorne, Australia, February 1994. Identification of two forms of mucin 1 - a secreted and splice variant lacking VNTR's

Xing, P.X., Prenzoska, J., Apostolopoulos, V. and McKenzie, I.F.C. Third International Workshop on Carcinoma-Associated Mucins. Cambridge, England, Aug. 1994. Monoclonal antibodies to MUC4 VNTR peptide.

Xing, P.X., Prenzoska, J., Ho, D., Apostolopoulos, V. McKenzie, I. Austin Hospital Research Week. Melbourne, Australia, October 1994. Monoclonal antibodies to tracheobronchial/colon mucin MUC4. 

Lees, C., Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. Immune Intervention - Vaccines Session. 24th Annual Scientific meeting, The Australasian Society for Immunology Inc., Canberra, Australian National University (ANU), Australia, Dec. 1994. A breast cancer vaccine based on a synthetic peptide. 

Apostolopoulos, V., Pietersz, G.A., Loveland, B.E. and McKenzie, I.F.C. Antigen Handling and Immune Regulation Poster Session. 24th Annual Scientific meeting, The Australasian Society for Immunology Canberra, ANU, Australia, Dec. 1994. Differential Immunisation to induce TH1 or TH2 immune responses. 

Xing, P.X., Apostolopoulos, V., Michaels, M., Prenzoska, J., Ho, D., Bishop, J. and McKenzie, I.F.C. 7th Lorne Cancer Conference, Lorne, Australia, February 1995. Phase I study of synthetic MUC1 peptides in breast cancer

Xing, P.X., Prenzoska, J., Ho, D., Apostolopoulos, V. McKenzie, I.F.C. 7th Lorne Cancer Conference, Lorne, Australia, February 1995. Monoclonal antibodies to tracheobronchial/colon mucin MUC4. 

Henning, M.M., Sandrin, M.S., Apostolopoulos, V., Williamson, J., Mottram, P., Purcell, L. and McKenzie, I.F.C. The Transplantation Society of Australia and New Zealand annual meeting, Canberra, Australia, March 1995. Transplantation in b2m-/- (MHC class I deficient) mice.

Apostolopoulos, V., Pietersz, G.A., Loveland, B.E and McKenzie, I.F.C. Cambridge Healthtech Institute. Cancer Vaccines, Virginia USA, June 1995. Differential Immunisation to induce TH1 or TH2 Immune Responses for Cancer Vaccines. 

Apostolopoulos, V., Pietersz, G.A., Acres, B. and McKenzie, I.F.C. The 4th International Conference on Gene Therapy of Cancer, San Diego USA, November 1995. Mannan MUC1-Fusion Protein and Gene Therapy. 

Apostolopoulos, V., Pietersz, G.A., Loveland, B.E. and McKenzie, I.F.C. 25th Annual Scientific meeting, The Australasian Society for Immunology Inc., Gold Coast, Queensland, Australia, Dec. 1995. Analysis of the Immune Responses and Mapping of Class I T cell epitopes presented by mice immunised with MFP.

Pietersz, G.A., Apostolopoulos, V., Popovski, V., Li, W. and McKenzie, I.F.C. 25th Annual Scientific meeting, The Australasian Society for Immunology Inc., Gold Coast, Queensland, Australia, December 1995. Use of Mannan as a Carrier for Vaccines.

Stambas, J., Apostolopoulos, V., Pietersz, G.A and Cheers, C. The 2nd Curtin Conference - Cytokines and the Immune Response, Canberra, Australia, January 1996. Induction of T1 cytokines by proteins linked to mannan.

McKenzie, I.F.C., Apostolopoulos, V., Acres, B. and Pietersz, G.A. Gene Therapy for Hematopoietic stem cells in Genetic diseases and Cancer. Taos, New Mexico, February 1996. MUC1 peptides, Mannan Fusion Protein and Gene Therapy. 

Pietersz, G.A., Apostolopoulos, V. and McKenzie, I.F.C. Cambridge Healthtech Institute. Vaccines: New Technologies and Applications, Virginia USA, March 1996. Immune Responses to Mannan-MUC1 Fusion Protein Conjugates: A Vaccine for Breast Cancer 

Pietersz, G.A., Lees, C.J., Apostolopoulos, V., Ong, C.S., Caruana, J., Popovski, V., Xing, P.X., Acre, B. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. Preclinical immunotherapy studies using MUC1-mannan fusion protein (M-FP) in combination with low dose cyclophosphamide, vv-cytokines or adjuvants

Karanikas, V., Hwang, L., Apostolopoulos, V. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. Induction of primary in vitro anti-MUC1 cytotoxic T lymphocyte responses in normal humans

Karanikas, V., Hwang, L., Apostolopoulos, V., Xing, P.X., Ong, C.S., Pietersz, G.A. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. Immune responses in patients with breast pancreatic and ovarian adenocarcinomas immunised with mannan-MUC1 fusion protein

Apostolopoulos, V., Pietersz, G.A., Lees, C.J., Popovski, V., Acres, B. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins. Cambridge, England, Aug. 1996. MUC1-H2 Interactions

Walsh, M.D., Cummings, M.C., Apostolopoulos, V., Xing, P.X., McKenzie, I.F.C. and McGuckin, M.A. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. MUC3 mucin antibodies reactive with paraffin-embedded human tissues

Acres, B., Apostolopoulos, V., Balloul, J.M., Pietersz, G.A., Bizouarne, N., Kieny, M.P. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, Aug. 1996. Immunotherapy of MUC-1 Expressing tumours in a mouse model with two different MUC1-based immunotherapy approaches

Lofthouse, S., Apostolopoulos, V., Pietersz, G. McKenzie, I.F.C. Austin Hospital Research Week. Melbourne, Australia, Oct 1996. Interleukin-1 as an adjuvant for active specific immunotherapy of cancer

Apostolopoulos, V., Lofthouse, S., Pietersz, G.A., Popovski, V., Osinski, C. and McKenzie, I.F.C. Austin Hospital Research Week. Melbourne, Australia, October 1996. The induction of cytotoxic T lymphocyte responses by conjugation of antigen to mannan

Lofthouse, S., Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. International Symposium - Cytokines and the Type I, Type II Paradigm, Cairns, Australia, October 1996. Interleukin-1 as an adjuvant for active specific immunotherapy of cancer

Lofthouse, S., Apostolopoulos, V., Pietersz, G.A., Popovski, V., Osinski, C., Ho. D. and McKenzie, I.F.C. International Symposium - Cytokines and the Type I, Type II Paradigm, Cairns, Australia, October 1996. The induction of cytotoxic T lymphocyte responses by conjugation of antigen to mannan

Lees, C.J., Apostolopoulos, V., Ong, C.S., Xing, P.X., Acres, B., Ramshaw, I., Matthaei, K. and McKenzie, I.F.C. 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, December 1996. Directing the T1/T2 immunogenicity pathways of a mucin-1 based vaccine with cytokines

Ho, D., Pietersz, G.A., Apostolopoulos, V., Popovski, V., Osinski, C. and McKenzie, I.F.C. 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, Dec. 1996. Use of mannan-peptide conjugates in vaccine studies

Pietersz, G.A., Li, W., Apostolopoulos, V., Toohey, B., Osinski, C. and McKenzie, I.F.C. 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, Dec. 1996. Immune responses to natural mucin and human MUC1 tandem repeat

Stambas, J., Apostolopoulos, V., Pietersz, G.A., McKenzie, I.F.C. and Cheers, C. 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, Dec. 1996. Induction of a T1 response by proteins linked to mannan 

Apostolopoulos, V., Chelvanayagam, G. and McKenzie, I.F.C. Antigen Processing and Presentation Workshop - 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, December 1996. The induction of CTL using M-FP: detection of multiple MUC1 epitopes which associate with Class I molecules in a novel manner 

Apostolopoulos, V., Karanikas, V., Sherman, L., Chelvanayagam, G. and McKenzie, I.F.C. Antigen Processing and Presentation Workshop - 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, December 1996. Induction of anti-MUC1 CTL presented by HLA-A2.1 molecules

Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. Antigen Processing and Presentation Workshop - 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, December 1996. Adoptive immunotherapy using macrophage/dendritic cells stimulated in vitro induce CTL in vivo

Apostolopoulos, V., Pietersz, G.A., Lees. C.J., Karanikas, V. and McKenzie, I.F.C. 1st Daydream Island Tumour Immunology Workshop, Queensland, Australia, December 1996. Immunogenicity of mannan-MUC1 peptides: Novel Class I peptide presentation and strategies to enhance the immunogenicity 

McKenzie, I.F.C., Apostolopoulos, V. and Pietersz, G. Keystone Meeting - Taos, New Mexico, February 1998. Oxidized Mannose Delivers Peptides Into the Class I MHC Presentation Pathway

Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. International Symposium. Advances in Peptide, Protein and Nucleic Acid, Vaccine Strategies. Oxford, England. July 1998. Aldehyde - mannan antigen complexes preferentially target the MHC Class I pathway

Karanikas, V., Pearson, J., Ong, C.S., Apostolopoulos, V., Gunawardana, D., Thyme, G. and McKenzie, I.F.C. 5th International Workshop on Carcinoma-Associated Mucins, Cambridge, England. July 1998. Phase I trials in patients with adenocarcinoma immunised with cyclophosphamide and mannan-MUC1 fusion protein

Pietersz, G., Li, W., Osinski, C., Apostolopoulos, V. and McKenzie, I.F.C. 5th International Workshop on Carcinoma-Associated Mucins, Cambridge, England. July 1998. Immune responses to non-variable number of tandem repeat (VNTR) sequences of human mucin 1 (MUC1) in mice

Apostolopoulos, V., McKenzie, I.F.C., Huang, M., Teyton, L., Chelvanayagam, G., and Wilson, I.A. West Coast Protein Crystallography Workshop. Asilomar Conference Center, Pacific Grove, CA USA. 2000. Unusual and novel features of peptide binding to MHC Class I molecules

Apostolopoulos, V., McKenzie, I.F.C., Teyton, L., Chelvanayagam, G., and Wilson, I.A. 90th American Association for Cancer Research. Philadelphia, PA USA. 2000. Unusual and novel features of peptide binding to MHC Class I molecules

Gong, J., Apostolopoulos, V., Chen, D., Koido, S., Rowse, G.J., Gendler, S.J., McKenzie, I.F.C., and Kufe, D. 90th American Association for Cancer Research. Philadelphia, PA USA. 2000. Identification of MUC1-specific CD8+ T cells in reversal of tolerance to MUC1 transgenic mice

Apostolopoulos, V., Yu, M., McKenzie, I.F.C., Teyton, L. and Wilson, I.A. Keystone Symposia on Molecular and Cellular Biology. Cellular Immunity and Immunotherapy of Cancer. Santa Fe, New Mexico USA. 2000. Novel features of peptide binding to MHC Class I molecules

McKenzie, I.F.C., Apostolopoulos, V., Yu, M., Wilson, I.A. Transplantation Society of Australia and New Zealand. Rome, Italy, 2000. Structural features of peptides binding MHC class I molecules.

Stratmann, T., Apostolopoulos, V., Mallet-Designe, V., Scott, C., Wilson, I.A., Kang, A. and Teyton, L. 39th Midwinter Immunology Conference, Asilomar Conference Center, Pacific Grove, CA USA. I-Ag7 and I-Ad side by side - what is the difference that leads to diabetes?

Apostolopoulos, V., Yu, M., Corper, A., Pietersz, GA., Wenjun, L., Teyton, L., McKenzie, I.F.C. and Wilson, I.A. West Coast Protein Crystallography Workshop. Asilomar Conference Center, Pacific Grove, CA USA, March 2001. Crystal Structures of Non Canonical Binding Peptides: Low Affinity Vs High Affinity Binding

Apostolopoulos, V., Yu, M., Corper, A., Pietersz, GA., Wenjun, L., Teyton, L., McKenzie, I.F.C. and Wilson, I.A. 31st Annual Meeting, Australasian Society for Immunology, Canberra, NSW Australia, December 2001. Crystal structure of a non-canonical low affinity peptide complexed with MHC class I: a new approach for vaccine design.

Apostolopoulos, V., Yu, M., Corper, A., Pietersz, GA., Wenjun, L., Teyton, L., McKenzie, I.F.C. and Wilson, I.A. Austin and Repatriation Medical Centre, 10th Annual Research Week, October 2002. Crystal structure of a non-canonical low affinity peptide complexed with MHC class I: a new approach for vaccine design.

Apostolopoulos, V., Pietersz, GA. and McKenzie, I.F.C. DAMD Era of Hope Congress, New York, NY USA. October 2002. Vaccine development against novel breast cancer antigens.

Son, H-Y., Kim, S-H., Lee, M-J., Kim, H-J., Chung, D-S., Park, S-O., Woo, J-K., Huh, J-W, Apostolopoulos, V. and Kim, C-W. 94th American Association for Cancer Research. Ontario, Toronto, Canada, 2003. Oxidative mannan as a useful adjuvant for T/Tn cancer vaccine.

Apostolopoulos, V., Yu, M., McKenzie, I.F.C. and Wilson, I.A. Vaccines and Immunotherapeutics, Keystone Resort, Keystone, Colorado, USA, January 2004. Novel modes of peptide binding to MHC class I: a new approach to peptide based vaccine design 

Plebanski, M., Flanagan, K., Reece, W.H.H., Pinder, M., Marsh, K., Hill, A.V.S. and Apostolopoulos, V. Howard Hughes Medical Institute Conference, Talinn, Estonia, June 2004. T cell epitope mapping in endemic populations: are we seeing the whole picture?

Maxwell, T., Sheng, K.C., Prato, S., Pinzon-Charry-A., Lincoln, D., Pietersz, G.A., Apostolopoulos, V., and Lopez, J.A. The 34th Annual Meeting, Australasian Society for Immunology, Adelaide, SA, Australia, December 2004. Mannan derivatives induce phenotypic and functional maturation of human monocyte-derived dendritic cells

Pouniotis, D.S., Pietersz, G.A., van Maanen, P.J., Andriessen, R.W., Lodding, J., Xing, P.X., McKenzie, I.F.C., Loveland, B.E. and Apostolopoulos, V. Tumour Immunology Workshop, Adelaide, SA, Australia, December 2004. Delivery of tumour antigens and cytotoxic T cell epitopes using a membrane translocating peptide induces cellular and protective immune responses.

Pouniotis, D.S., Apostolopoulos, V*. and McDonald, C.F*. Annual meeting of the Thoracic Society of Australia and New Zealand (TSANZ). Perth, WA, Australia, March 2005. (* equal contribution). Alveolar macrophage function is altered in patients with primary lung cancer 

Pietersz, G.A., Pouniotis, D.S., Apostolopoulos, V. The 2005 Komen Foundation Mission Conference, A promise in action. Washington DC, USA, June 2005. Membrane translocating peptides and immune responses to MUC1 antigens

Pietersz, G.A., Tang, C.K., Lodding, J., McKenzie, I.F.C. and Apostolopoulos, V. Mucins in Health and Disease (8th International Workshop on Carcinoma-Associated Mucins). Cambridge, UK, July 2005. Novel non-viral receptor mediated gene transfer ligands for cancer immunotherapy: oxidised and reduced mannan

Tang, C.K., Pietersz, G.A., Lodding, J., Minigo, G., Pouniotis, D., Plebanski, M., McKenzie, I.F.C. and Apostolopoulos, V. Austin Health Research Week, Heidelberg, VIC Australia, October 2005. Novel non-viral gene delivery vectors for cancer immunotherapy: oxidised and reduced mannan

Katsara M,, Tselios T., Deraos S., Deraos G., Matsoukas J. and Apostolopoulos, V. Austin Health Research Week, Heidelberg, VIC Australia, October 2005. Myelin Basic Protein (MBP) and Proteolipid Protein (PLP) Peptides (linear and cyclic, agonist and antagonist): Immunomodulating Therapeutic Approaches for Multiple Sclerosis

Sheng, K-C., Pietersz, G.A., Pouniotis, D., Wright, M.D and Apostolopoulos, V. Austin Health Research Week, Heidelberg, VIC Australia, October 2005. Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells

Katsara M,, Tselios T., Deraos S., Deraos G., Matsoukas J. and Apostolopoulos, V. Alfred Medical Research Week, Melbourne VIC Australia, October 2005. Effect of myelin basic protein (MBP) and Proteolipid protein (PLP) peptides (linear and cyclic) using CFA or conjugated to reduced mannan in animal models for Multiple Sclerosis.

Tang, C.K., Pietersz, G.A., Lodding, J., Minigo, G., Pouniotis, D., Plebanski, M., McKenzie, I.F.C. and Apostolopoulos, V. Alfred Medical Research Week, Melbourne VIC Australia, October 2005. Novel non-viral gene delivery vectors for cancer immunotherapy: oxidised and reduced mannan

Sheng, K-C., Pietersz, G.A., Pouniotis, D., Wright, M.D and Apostolopoulos, V. Alfred Medical Research Week, Melbourne VIC Australia, October 2005. Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells

Pouniotis, D.S., Pietersz, G.A and Apostolopoulos, V. Alfred Medical Research Week, Melbourne VIC Australia, October 2005. Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses

Gartlan, K.H., Nastovska, R., Van Spriel, A., Sheng, K.C., Robb, G., Pietersz, G.A., Apostolopoulos, V. and Wright, M.D. Alfred Medical Research Week, Melbourne VIC Australia, October 2005. The Immune Function of mice deficient for the tetraspanin proteins CD37 and Tssc6. 

Katsara M,, Tselios T., Deraos S., Deraos G., Matsoukas J. and Apostolopoulos, V. 35th Australasian Society for Immunology. Melbourne, Australia, December 2005. Myelin Basic Protein (MBP) and Proteolipid Protein (PLP) Peptides (linear and cyclic) and immune responses in animal models. Therapeutic Approaches for Multiple Sclerosis

Tang, CK., Lodding, J., Minigo, G., McKenzie, IFC., Pouniotis, DS., Scholzen, A., Plebanski, M., Pietersz, G.A. Apostolopoulos, V. 35th Australasian Society for Immunology. Melbourne, Australia, Dec 2005. Oxidised and reduced mannan as receptor mediated gene delivery vehicles

Sheng, KC., Pouniotis, DS., Wright, MD, Tang, CK, Pietersz, GA. and Apostolopoulos, V. 35th Australasian Society for Immunology. Melbourne, Australia, December 2005. Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells

Pouniotis, D.S., Apostolopoulos, V. and Pietersz, G.A. 35th Australasian Society for Immunology. Melbourne, Dec 2005. Mechanism of uptake, processing and class I/II presentation of protein and peptides linked to membrane translocating peptides.

Gartlan, K.H., Nastovska, R., van Spriel, A., Sheng, K.C., Lazoura, E., Robb, G., Pietersz, G.A., Apostolopoulos, V. and Wright, M.D. 35th Australasian Society for Immunology. Melbourne, Australia, December 2005. The Immune Function of mice deficient in expression of the tetraspanin genes CD37 and Tssc6. 

Maxwell, T., Tang, C.T., Forster, T., Pietersz, G.A., Apostolopoulos V. and Lopez, J.A. 35th Australasian Society for Immunology. Melbourne, Australia, December 2005. Efficient antigen delivery into dendritic cell by transfection of mRNA conjugated with oxidised-mannan and polyethylenimine. 

Pietersz, G,A., Esparon, S., Proudfoot, O., Lodding, J., Singh, Y., Meanger, J., Plebanski, M., Hogarth, M., Coulson, B., Apostolopoulos, V. and Cheers, C. 35th Australasian Society for Immunology. Melbourne, Australia, December 2005. Development of mucosal vaccines for respiratory syncytial virus, bacillus anthracis and rotavirus based on oxidised mannan.

Katsara, M., Deraos, G., Tselios, T., Deraos, S., Matsoukas, J and Apostolopoulos, V. 7th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Dept Chemistry & Pharmacology. Patras Greece. March 2006. Immune responses of myelin basic protein (MBP83-99) analogues (alone or conjugated with mannan) in SJL/J mice.

Katsara, M., Tselios, T., Deraos, S., Deraos, G., Matsoukas, J and Apostolopoulos, V. 1st Australasian vaccines and immunotherapeutics development meeting. Bio21 Molecular Science and Biotechnology Institute, VIC Australia. May 2006. Myelin basic protein (MBP) and proteolipid protein (PLP) peptides (linear and cyclic) and immune responses in SJL mice: Immunotherapeutic approaches for multiple sclerosis

Tang, CK., Lodding, J., Minigo, G., McKenzie, IFC., Scholzen, A., Pouniotis, DS., Plebanski, M., Pietersz, G.A. Apostolopoulos, V. 1st Australasian vaccines and immunotherapeutics development meeting. Bio21 Institute, VIC Australia. May 2006. Oxidised and reduced mannan as receptor mediated gene delivery vehicles

Lazoura, E., Lodding, J., Farrugia, W., Ramsland, P.A., Stevens, J., Wilson, I.A., Pietersz, G.A and Apostolopoulos, V. 1st Australasian vaccines and immunotherapeutics development meeting. Bio21 Institute, VIC Australia. May 2006. Anchor modification of non-canonical tumour associated MUC1-8 peptide, with enhanced MHC class I binding and immune responses – crystal structure and biological data.

Pouniotis, D.S., McDonald, C. and Apostolopoulos, V. 1st Australasian vaccines and immunotherapeutics development meeting. Bio21 Molecular Science and Biotechnology Institute, VIC Australia. May 2006. Alveolar macrophage function is altered in patients with lung cancer.

Pouniotis, D., Pietersz, G.A. and Apostolopoulos, V. 1st joint meeting of European National Societies of Immunology (ECI). Paris, France. September 2006. Penetratin linked to proteins or peptides induce cellular and protective immune responses via diverse processing mechanisms

Maxwell, T., Tang, C.K., Forster, T., Pietersz, G.A., Apostolopoulos V. and Lopez, J.A. 1st joint meeting of European National Societies of Immunology (ECI). Paris, France. September 2006. A novel dendritic cell RNA delivery strategy for cancer immunotherapy

Maxwell, T., Tang, C.K., Forster, T., Pietersz, G.A.,Apostolopoulos V. and Lopez, J.A. 9th International conference on
dendritic cells (DC2006), Edinburgh, Scotland. September 2006. A novel dendritic cell RNA delivery strategy for cancer immunotherapy

Gartlan, K., van Spriel, A.B., Nastovska, R., Sofi, M., Sheng, K.C., Robb, L., Pietersz, G.A., Apostolopoulos V. and Wright, M.D. 4th FASEB – Membrane organisation by tetraspanins and small multi-transmembrane proteins. Tucson, AZ, USA. July 2006. Immune function in mice deficient for the expression of both tetraspanins CD37 and Tssc6.

van Spriel, A.B., Gartlan, K., Sheng, K.C., Sofi, M., Daunt, C., Robb, L., Apostolopoulos V. and Wright, M.D. 4th FASEB – Membrane organisation by tetraspanins and small multi-transmembrane proteins. Tucson, AZ, USA. July 2006. Dendritic cell function in mice lacking CD37, Tssc6 and CD151.

Apostolopoulos, V., Pietersz, G.A., Tsibanis, A., Tsikkinis, A., Drakaki, H., Loveland, B.E., Piddlesden, S.J., Plebanski, M., Pouniotis, D.S., Alexis, M.N., McKenzie, I.F.C. and Vassilaros, S. 1st Australasian vaccines and immunotherapeutics development meeting. Bio21 Molecular Science and Biotechnology Institute, VIC Australia. May 2006. Human clinical trials: Oxidised mannan-MUC1 in Pilot Phase III immunotherapy study in early stage breast cancer patients

Deraos G., Katsara M,, Tselios T., Deraos S., Apostolopoulos, V. and Matsoukas J. 29th European Peptide Symposium, Gdansk, Poland. September 2006. Design and synthesis of Myelin Basic Protein (MBP) linear and cyclic peptide analogues complexed with mannan: Effects in cytokine production.

Katsara, M., Tselios, T., Matsoukas, J and Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Novel linear and cyclic GnRH analogues inhibit proliferation of the human tumour cell line MCF7 

Katsara, M., Deraos, G., Matsoukas, J and Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Rational altered peptide ligands of Myelin basic protein for immunotherapy of multiple sclerosis

Katsara, M., Tselios, T., Matsoukas, J and Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Design, synthesis and immunological studies of linear and cyclic altered peptide ligands of myelin basic protein MBP87-99 epitope

Lodding, J., Lazoura, E., Farrugia, W., Ramsland, P.A., Stevens, J., Wilson, I.A., Pietersz, G.A. and Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Enhanced MHC class I binding and immune responses through anchor modification of the non-canonical tumour associated MUC1-8 peptides

Sheng, KC., Gartlan, K., Sofi, M., Moseley, G., Ashman, L., Pietersz, G.A., Wright, M.D. and Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Immunological function of tetraspanin CD151

Sheng, KC., Kalkanidis, M., Wright, M.D., Esparon, S., Pouniotis, D.S., Tang, C.K., Lazoura, E., Pietersz, G.A. and Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Polymannose potentiates antigenicity via enhanced antigen presentation and functional maturation of mouse dendritic cells

Gartlan, K., Belz, G., Kyparissoudis, K., Nastovska, R., Robb, L., Pietersz, G.A., Apostolopoulos V., Godfrey, D.I. and Wright, M.D. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. The tetraspanins CD37 and Tssc6 play a complimentary role in immune function.

Dais, A., Friligou, I., Matsoukas, J., Apostolopoulos, V., Pietersz, G.A. and Gatos, D. 2nd Biotechnology Conference, Patras, Greece. April 2007. Design and synthesis of dendrimers using peptide analogues of MUC1 protein for the immunotherapy of cancer

Pietersz, G,A., Tang, C.K., Sheng, K,C., Maxwell, T., Pouniotis, D.S., Lodding, J., Minigo, G., Plebanski, M., McKenzie, I.F.C., Lopez, A. and Apostolopoulos, V. 9th International workshop on carcinoma-associated mucins. Mucins in health and disease. Cambridge, UK. July 2007. Mannan-mediated delivery of protein, DNA and RNA to antigen presenting cells. 

Pouniotis, D.S., Pietersz, G.A. and Apostolopoulos V. 9th International workshop on carcinoma-associated mucins. Mucins in health and disease. Cambridge, UK. July 2007. Delivery of tumour associated antigens to antigen presenting cells using penetratin induces potent immune responses

Sheng, K.C., Kalkanidis, M., Pietersz, G.A and Apostolopoulos V. 5th International conference. DC2007 – Dendritic cell vaccination and other strategies to tip the balance of the immune system. Bamberg, Germany. July 2007. A novel mannose-based antigen delivery system potentiates immunogenicity via specific DC subtypes and TLR4 functionality

Pouniotis, D.S., Pietersz, G.A* and Apostolopoulos, V*. 5th International conference. DC2007 – Dendritic cell vaccination and other strategies to tip the balance of the immune system. Bamberg, Germany. July 2007. [*equal contribution]. Delivery of tumor antigens using a membrane translocating peptide to DC induces cellular and protective immune responses. 

Pouniotis, D.S., Pietersz, G.A. and Apostolopoulos V. The next Intracellular Delivery of Therapeutic Macromolecules: from Concept to Application in Grenoble September 19-21, 2007. Delivery of tumour associated antigens to antigen presenting cells using penetratin induces potent immune responses

Kalkanidis, M., Sheng, K.C., Apostolopoulos V. and Pietersz, G.A. 5th International Dendrimer Symposium, Toulouse, France. September 2007. Immune responses and design of mannosylated dendrimers. 

Katsara, M., Deraos, G., Matsoukas, J. and Apostolopoulos, V. 4th International / 7th Australian Peptide Conference. Cairns, Australia. October 2007. T cell receptor altered peptide ligands of Myelin Basic Protein (MBP) and Proteolipid Protein (PLP) peptides (Linear and Cyclic) can modulate immune responses in SJL/J mice: Bioactive peptides for Multiple Sclerosis. 

Katsara, M., Deraos, G., Matsoukas, J. Apostolopoulos, V. Austin Health Research Week, Heidelberg VIC Australia. October 2007. A single or double TCR altered peptide ligands of Myelin Basic Protein (MBP) and Proteolipid Protein (PLP) (Linear and Cyclic) can modulate immune responses in SJL/J mice. 

Apostolopoulos V. 5th International workshop on antigen processing and presentation. Dunk Island, North Queensland, Australia. October 2007. Non canonical peptide complexes with MHC class I or II: are we seeing the whole picture

Katsara, M., Deraos, G., Matsoukas, J. and Apostolopoulos, V. Progress in Multiple Sclerosis Research, WEHI, VIC, Australia. November 2007. A single or double TCR altered peptide ligands of Myelin Basic Protein (MBP) and Proteolipid Protein (PLP) (Linear and Cyclic) can modulate immune responses in SJL/J mice. 

Vassilaros, S., Tsibanis, A., Tsikkinis, A., Drakaki, E., McKenzie, I. and Apostolopoulos, V. San Antonio Breast Cancer Symposium, USA. December 2007. Ten year follow up of patients with early stage breast cancer of pilot phase III immunotherapy study

Apostolopoulos V. 37th Australasian Society for Immunology. Sydney Australia, December 2007. Non canonical peptide complexes with MHC class I or II: are we seeing the whole picture

Apostolopoulos, V. McKenzie, I. Pietersz, G. Vassilaros, S. 37th Australian Society for Immunology. Sydney Australia, Dec 2007. Ten year follow up of patients with early stage breast cancer of pilot phase III immunotherapy study

Gartlan, K., Belz, G., Kyparissoudis, K., Nastovska, R., Robb, L., Pietersz, G.A., Apostolopoulos V., Godfrey, D.I. and Wright, M.D. 2nd European Tetraspanin Symposium. Madrid, Spain, 2007. The tetraspanins CD37 and Tssc6 play a complimentary role in immune function.

Pouniotis, D.S., Brooks, N., Perret, J., Apostolopoulos, V., McDonald, C.F. The Thoracic society of Australia and New Zealand, Melbourne Convention Center, Australia, March, 2008. Blood monocytes function from patients with early diagnosed primary lung cancer

Perret, J., Apostolopoulos, V., McDonald, C.F., Pouniotis, D.S. The Thoracic society of Australia and New Zealand, Melbourne Convention Center, Australia, March, 2008. T helper-17 cell responses in chronic obstructive pulmonary disease: a pilot study

Katsara, M., Yuriev, E., Ramsland, P., Deraos, G., Tselios, T., Deraos, S., Matsoukas, J. and Apostolopoulos, V. 9th International Conference in Medicinal Chemistry: Drug Discovery and Design. University of Patras, Departments of Chemistry and Pharmacology. Patras, Greece. March 2008. Linear/cyclic mutant analogues of self antigens (MBP and PLP) manipulate immune responses in mice

Tang, C.K., Pietersz, G.A. Apostolopoulos, V. 2nd AVID meeting. Surfers Paradise, Australia. May 2008. Oxidised mannan potentiates DNA vaccine for use in cancer immunotherapy

Katsara, M., Yuriev, E., Ramsland, P., Deraos, G., Matsoukas, J. and Apostolopoulos, V. 30th European Peptide Symposium (30EPS), Helsinki, Finland. September 2008. Development of a vaccine against Multiple Sclerosis

Deraos, G., Chatzantoni, K., Matsoukas, M-T., Katsara, M., Tselios, T., Deraos, S., Papathanasopoulos, P., Vynios, D., Apostolopoulos, V., Mouzaki, A. and Matsoukas, J. 30th European Peptide Symposium (30EPS), Helsinki, Finland. September 2008. Modifications of the myelin basic protein epitope MBP87-99 divert Th2 to Th1: immune responses in PBMC from MS patients

Perret, J., Pouniotis, D.S., McDonald, C. and Apostolopoulos, V. Austin Medical Research Week, Melbourne VIC October, 2008. T helper-17 cell responses in chronic obstructive pulmonary disease (COPD): A pilot study

Day, S., Slaats, I., Sheng, K-C. and Apostolopoulos, V. 38th Australasian Society for Immunology. Canberra, ACT Australia, December 2008. Functional characterisation of Muc1 on murine lymphocytes

Brooks, N., Pouniotis, D.S., Apostolopoulos, V. and Pietersz, G.A 38th Australasian Society for Immunology. Canberra, ACT Australia, December 2008. Delivery of multiple tumour epitopes by membrane translocating peptides

Tang, C.K., Apostolopoulos, V. and Pietersz, G.A 38th Australasian Society for Immunology. Canberra, Australia, December 2008. Immune responses and mechanism of action induced by mannan mediated DNA vaccination

123.Sheng, K-C., Pietersz, G.A. and Apostolopoulos, V. Dendritic cells. Keystone Symposia, Fairmont Banff Springs, Banff, Alberta Canada. March 2009.
The functionality of GM-CSF induced bone-marrow-derived dendritic cells is dependent on their developmental stage

Apostolopoulos, V. 5th Australian Health and Medical Research Congress, Melbourne, Australia, November 2010. Early breast cancer patients immunised with mannan-MUC1: 12 year followup

Mailins, L.R., Wilkinson, B., Day, S., Apostolopoulos, V. and Payne, R. Royal Australian Chemical Society Symposium, Sydney, NSW Australia, Febriuary 2011. Best Poster Award. Synthesis and biological evaluation of glycopeptides cancer vaccine candidates

Day, S., Wilkinson, B., Payne, R. and Apostolopoulos, V. Keystone Symposia – New Frontiers at the interface of immunity and glycobiology. Lake Louise, Alberta Canada, March 2011. Chemical synthesis and immunological evaluation of MUC1 glycopeptide tumour vaccine candidates

Kong, Y.Y., Fuchsberger, M., Apostolopoulos, V. and Plebanski, M. Australian Society of Immunology, Adelaide Australia, December 2011. Effects of cancer cells on the dendritic cell lineage

Vassilaros, S., Tsibanis, A., Tsikkinis, A., Drakaki, E., McKenzie, I. and Apostolopoulos, V. San Antonio Breast Cancer Symposium, USA. December 2012. 13 year clinical follow-up of pilot phase III immunotherapy study in stage II breast cancer patients using oxidised mannan-MUC1

Perera, C.J., Zahrooni, S., Apostolopoulos, V. and Moalem-Taylor, G. 4th International congress on neuropathic pain: The pain to relief starts with understanding. Toronto, Canada. May 2013. Immunisation with myelin-derived altered peptide ligands inhibits neuropathic pain following peripheral nerve injury

Katsara, M., Grigoriadis, N., Yuriev, E., Ramsland, P.A., Deraos, G., Matsoukas, J. and Apostolopoulos, V. Helani Congress of Neuroimmunology for Multiple Sclerosis, Athens, Greece, October 2013. Mannosylation of mutated MBP83-99 peptides diverts immune responses from Th1 to Th2 in SJL/J mice: Bioactive peptides for Multiple Sclerosis

Apostolopoulos, V. 5th Australasian vaccines and immunotherapeutics development (AVID) meeting. Burnet Institute, Melbourne VIC Australia, May 2014. Clinical study in stage II breast cancer patients using oxidised mannan-MUC1: clinical data 16.5 years on

Perera, C.J., Apostolopoulos, V. and Moalem-Taylor, G. 15th World Congress on Pain. International Association for the Study of Pain. Buenos Aires, Argentina, October 2014. Active immunisation with myelin basic protein and myelin-derived altered peptide ligand elicits differential effects on pain behaviours in normal and spinal cord-injured rats






​                  --------------------------------------------------------------------------------------------------------------------------------------------------------------
                  --------------------------------------------------------------------------------------------------------------------------------------------------------------








CONFERENCE ABSTRACTS 

Summary Conference Abstracts: Total - 255   
1st author - 80
Last author - 81 (all post 2004)





Apostolopoulos, V., Xing, P.X., Trapani, J. and McKenzie, I.F.C. 21st Annual Scientific meeting, The Australian Society for Immunology Inc., Perth, Australia, Dec. 1991. Monoclonal antibodies reactive with mucins expressed in breast cancer

Apostolopoulos, V., Xing, P.X., Trapani, J. and McKenzie, I.F.C. Australian Institute of Medical Scientists, State Scientific Meeting., Bairnsdale, Australia, March 1992. New monoclonal antibodies reactive with mucins expressed in breast cancer. 

Xing, P.X., Apostolopoulos, V. Prenzoska, J., Ho, D., Devine, P. and McKenzie, I.F.C. Second International Workshop on Carcinoma-Associated Mucins., Cambridge, England, Aug. 1992. Peptide epitopes detected by anti-mucin antibodies. 

Apostolopoulos, V., Xing, P.X. and McKenzie, I.F.C. 36th Annual Conference, The Australian Society for Biochemistry and Molecular Biology Inc., Melbourne, Australia, Sept. 1992. Second generation MUC3 peptide monoclonal antibodies reactive with colon cancer.  

Apostolopoulos, V., Xing, P.X. and McKenzie, I.F.C. 1st Inaugural meeting, The Australasian Society for Immunology, Immunology group of Victoria. W.E.H.I Melbourne, Australia, Oct. 1992. Second generation monoclonal antibodies to intestinal Mucin 3.  

Apostolopoulos, V., Xing, P.X., Prenzoska, J. and McKenzie, I.F.C. 1st Inaugural meeting, The Australasian Society for Immunology, Immunology group of Victoria., W.E.H.I Melbourne, Australia, Oct. 1992. Immunotherapy for Breast Cancer.

Apostolopoulos, V., Xing, P.X. and McKenzie, I.F.C. 22nd Annual Scientific meeting, The Australasian Society for Immunology Inc., Auckland, New Zealand, Dec. 1992. Second generation monoclonal antibodies reactive with gastrointestinal mucins.  

Apostolopoulos, V., Xing, P.X., Prenzoska, J. and McKenzie, I.F.C. 22nd Annual Scientific meeting, The Australasian Society for Immunology Inc., Auckland, New Zealand, Dec. 1992. Immunotherapy for Breast Cancer. 

Xing, P.X., Apostolopoulos, V., Prenzoska, J. and McKenzie, I.F.C. In: 5th International Workshop on Monoclonal Antibodies and Breast Cancer, San Francisco, 1992. Peptide epitopes detected by anti-mucin antibodies. 

Xing, P.X., Apostolopoulos, V.  Prenzoska, J., Devine, P. and McKenzie, I.F.C. 5th Lorne Cancer Conference, Lorne, Australia, Feb. 1993. Epitopes detected by anti-mucin monoclonal antibodies. 

McKenzie, I., Apostolopoulos, V. and Xing, P.X. J. Cell. Biochem. Abstract Supplement, Taos, New Mexico, 17D:195, March 1993. Immunotherapy for breast cancer with synthetic peptides.  

Apostolopoulos, V., Xing, P.X. and McKenzie, I.F.C. Austin Hospital Research Week. Melbourne, Australia, Oct. 1993. Use of synthetic peptides to immunise against breast cancer.

Apostolopoulos, V., Xing, P.X., Pietersz, G.A. and McKenzie, I.F.C. 20th Annual Scientific meeting of the Clinical Oncological society of Australia (COSA). Perth, Australia, Nov. 1993. Use of synthetic peptides to immunise against breast cancer. 

Apostolopoulos, V., Xing, P.X., Pietersz, G.A. and McKenzie, I.F.C. International Congress on the Regulation of Leukocyte Production and Immune Function. The Australasian Society for Immunology Inc. and International Society for Leukocyte Biology, joint meeting. Sydney, Australia, Dec. 1993. Use of synthetic peptides to immunise against breast cancer. 

McKenzie, I.F.C., Apostolopoulos, V., Xing, P.X. and Pietersz, G.A. International Congress on the Regulation of Leukocyte Production and Immune Function. The Australasian Society for Immunology Inc. and International Society for Leukocyte Biology, joint meeting. Sydney, Australia, Dec. 1993. Is a breast cancer vaccine feasible?  

Apostolopoulos, V., Xing, P.X., Pietersz, G.A. and McKenzie, I.F.C. 6th Lorne Cancer Conference, Lorne, Australia, Feb. 1994. Is a breast cancer vaccine feasible?

Xing, P.X., Apostolopoulos, V., Prenzoska, J., Wreschner, D. and McKenzie, I.F.C. 6th Lorne Cancer Conference, Lorne, Australia, February 1994. Identification of two forms of mucin 1 - a secreted and splice variant lacking VNTR's.  

Apostolopoulos, V., Xing, P.X., Pietersz, G.A. and McKenzie, I.F.C. NATO ASI: Vaccines: New-Generation Immunological Adjuvants. Cape Sounion Beach, Greece, June 1994. Differential immunisation to induce humoral and cellular immunity for cancer vaccines.

McKenzie, I.F.C.,  Apostolopoulos, V., Xing, P.X., Pietersz, G.A., Acres, B., Michaels, M. and Bishop, J. In: Third International Workshop on Carcinoma-Associated Mucins, Cambridge, England, August 1994. The immunogenicity of MUC1 peptides and fusion protein. 

Xing, P.X., Prenzoska, J., Apostolopoulos, V. and McKenzie, I.F.C. In: Third International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1994. Monoclonal antibodies to MUC4 VNTR peptide.  

McKenzie, I.F.C., Apostolopoulos, V., Xing, P.X., Pietersz, G.A., Acres, B., Michaels, M., and Bishop, J. 20th meeting of the International association for breast cancer research. Sendai, Japan, September 1994. The immunogenicity of MUC1 peptides and fusion protein.  

Xing, P.X., Prenzoska, J., Apostolopoulos, V., Ho, D., Willsher, P. and McKenzie, I.F.C. Austin Hospital Research Week. Melbourne, Australia, October 1994. Monoclonal antibodies to tracheobronchial/colon mucin MUC4.  

Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. 33rd National Scientific Conference, Australian Society for Medical Research. Melbourne, Australia, November 1994. Is a breast cancer vaccine feasible?  

Lees, C.J., Apostolopoulos, V., Pietersz, G.A. McKenzie, I.F.C. 24th Annual Scientific meeting, The Australasian Society for Immunology Inc., Canberra, Australian National University, Australia, December 1994. A breast cancer vaccine based on a synthetic peptide.  

Apostolopoulos, V., Pietersz, G.A., Loveland, B. McKenzie, I. 24th Annual Scientific meeting, The Australasian Society for Immunology, Canberra, Australian National University, Australia, December 1994. Differential Immunisation to induce TH1/TH2 immune responses. 

Xing, P.X., Apostolopoulos, V., Michaels, M., Prenzoska, J., Bishop, J. and McKenzie, I.F.C. 7th Lorne Cancer Conference, Lorne, Australia, February 1995. Phase I study of synthetic MUC1 peptides in breast cancer.  

Xing, P.X., Prenzoska, J., Ho, D., Apostolopoulos, V. and McKenzie, I. 7th Lorne Cancer Conference, Lorne, Australia, Feb. 1995. Monoclonal antibodies to tracheobronchial/colon mucin MUC4. 

Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. 7th Lorne Cancer Conference, Lorne, Australia, February 1995. Immunotherapy for breast cancer using a carbohydrate-antigen conjugate. 

Henning, M.M., Sandrin, M.S., Apostolopoulos, V., Williamson, J., Mottram, P., Purcell, L. and McKenzie, I.F.C. The Transplantation Society of Australia and New Zealand annual meeting, Canberra, Australia, March 1995. Transplantation in b2m-/- mice . 

Apostolopoulos, V., Xing, P.X., Loveland, B.E., Pietersz, G.A. and McKenzie, I.F.C. Control and manipulation of the Immune response: Immunity to bacteria, parasites, tumours and allografts. Taos, New Mexico, March 1995. The immunogenicity of MUC1 peptides and mannan fusion protein (MFP). 

Apostolopoulos, V., Pietersz, G.A., Loveland, B.E and McKenzie, I.F.C. Cambridge Healthtech Institute. Cancer Vaccines, Virginia USA, June 1995. Differential Immunisation to induce TH1 or TH2 Immune Responses for Cancer Vaccines.  

Apostolopoulos, V., Pietersz, G.A., Loveland, B.E and McKenzie, I.F.C. The 9th International Congress of Immunology, San Francisco, California USA, July 1995. Differential Immunisation to induce T1 or T2 Immune Responses for Cancer Vaccines.  

Apostolopoulos, V., Pietersz, G.A., Loveland, B.E. and McKenzie, I.F.C. 4th Annual Conference of The Immunology Group of Victoria, W.E.H.I. Melbourne, Australia, October 1995. Analysis of the Immune Responses Generated by Mice Immunised with Mannan-Fusion Protein.

McInnes, B., Ostenried, K., Apostolopoulos, V., McKenzie, I.F.C. and Hogarth, P.M. ThymOz - An International Workshop on T Lymphocytes. Heron Island, Australia, October 1995. Analysis of in vivo function of membrane-bound and soluble Fc receptor for IgG in mice transgenic for Human FcgRIIa.

Apostolopoulos, V., Pietersz, G.A., Acres, B. and McKenzie, I.F.C. The 4th International Conference on Gene Therapy of Cancer, San Diego USA, November 1995. Mannan MUC1-Fusion Protein and Gene Therapy. 

Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. 34th National Scientific Conference, Australian Society for Medical Research. Leura - NSW, Australia, November 1995. A breast cancer vaccine within sight?  

Apostolopoulos, V., Pietersz, G.A., Loveland, B.E. and McKenzie, I.F.C. 25th Annual Scientific meeting, The Australasian Society for Immunology Inc., Gold Coast, Queensland, Australia, December 1995. Analysis of the Immune Responses and Mapping of T cell epitopes presented by mice immunised with MFP.

Pietersz, G.A., Apostolopoulos, V., Popovski, V., Li, W. and McKenzie, I.F.C. 25th Annual Scientific meeting, The Australasian Society for Immunology Inc., Gold Coast, Queensland, Australia, December 1995. Use of Mannan as a Carrier for Vaccines.

Stambas, J., Apostolopoulos, V., Pietersz, G.A and Cheers, C. The 2nd Curtin Conference - Cytokines and the Immune Response, Canberra, Australia, January 1996. Induction of T1 cytokines by proteins linked to mannan.

Apostolopoulos, V., Ong, CS., Lees, C.J., Pietersz, G.A., Xing, P.X., Acres, B. and McKenzie, I.F.C. The 2nd Curtin Conference - Cytokines and the Immune Response, Canberra, Australia, January 1996. Cancer vaccine studies using mannan-fusion protein (MFP) and cytokines.

McKenzie, I.F.C., Apostolopoulos, V., Acres, B. and Pietersz, G.A. Gene Therapy for Hematopoietic stem cells in Genetic diseases and Cancer. Taos, New Mexico, February 1996. MUC1 peptides, Mannan Fusion Protein and Gene Therapy. 

Pietersz, G.A., Apostolopoulos, V. and McKenzie, I.F.C. Cambridge Healthtech Institute. Vaccines: New Technologies and Applications, Virginia USA, March 1996. Immune Responses to Mannan-MUC1 Fusion Protein conjugates: A vaccine for breast cancer 

McKenzie, I.F.C., Apostolopoulos, V., Pietersz, G.A., and Acres, B.A. International Association for Breast Cancer Research. Paris, France, July 1996. Tumour Immunotherapy against MUC1 expressing tumours using mannan MUC1

Apostolopoulos, V., Pietersz, G.A., Lees, C.J., Popovski, V., Acres, B. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. Immunogenicity of mannan-MUC1 peptides: Class I restricted mouse/human T cell epitopes and strategies to enhance immunogenicity of MUC1

Apostolopoulos, V., Pietersz, G.A., Acres, B. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. Immunisation to induce Th1 and/or Th2 immune responses for cancer vaccines and the development of various tumour models for immunotherapy

Apostolopoulos, V., Chelvanayagam, G. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. The induction of CTL using M-FP: detection of multiple MUC1 epitopes which associate with Class I molecules in a novel manner and are accessible to anti-MUC1 peptide antibodies

Apostolopoulos, V., Karanikas, V., Sherman, L., Chelvanayagam, G. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. Induction of anti-MUC1 CTL presented by HLA-A2.1 molecules

Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. Adoptive immunotherapy using macrophage/dendritic cells stimulated in vitro induce CTL in vivo

Karanikas, V., Hwang, L., Apostolopoulos, V. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, Aug. 1996. Induction of primary in vitro anti-MUC1 cytotoxic T lymphocyte responses in normal humans

Karanikas, V., Hwang, L., Apostolopoulos, V., Xing, P.X., Ong, C.S., Pietersz, G.A. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. Immune responses in patients with breast pancreatic and ovarian adenocarcinomas immunised with mannan-MUC1 fusion protein

Pietersz, G.A., Lees, C.J., Apostolopoulos, V., Ong, C.S., Caruana, J., Popovski, V., Xing, P.X., Acre, B. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. Preclinical immunotherapy studies using MUC1-mannan fusion protein (M-FP) in combination with low dose cyclophosphamide, vv-cytokines or adjuvants

Pietersz, G.A., Li, W., Toohey, B., Ho, D., Popovski, V., Apostolopoulos, V. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. Immune responses to human milk fat globule membrane antigen, human MUC1 VNTR and MUC1-KLH conjugated to mannan

Walsh, M.D., Cummings, M.C., Apostolopoulos, V., Xing, P.X., McKenzie, I.F.C. and McGuckin, M.A. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. MUC3 mucin antibodies reactive with paraffin-embedded human tissues

Acres, B., Apostolopoulos, V., Balloul, J.M., Pietersz, G.A., Bizouarne, N., Kieny, M.P. and McKenzie, I.F.C. 4th International Workshop on Carcinoma-Associated Mucins., Cambridge, England, August 1996. Immunotherapy of MUC-1 Expressing tumours in a mouse model with two different MUC1-based immunotherapy approaches

Lofthouse, S., Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. International Symposium - Cytokines and the Type I, Type II Paradigm, Cairns, Australia, October 1996. Interleukin-1 as an adjuvant for active specific immunotherapy of cancer

Lofthouse, S., Apostolopoulos, V., Pietersz, G.A., Popovski, V., Osinski, C., Ho. D. and McKenzie, I.F.C. International Symposium - Cytokines and the Type I, Type II Paradigm, Cairns, Australia, October 1996. The induction of cytotoxic T lymphocyte responses by conjugation of antigen to mannan

Lofthouse, S., Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. Austin Hospital Research Week. Melbourne, Australia, October 1996. Interleukin-1 as an adjuvant for active specific immunotherapy of cancer

Apostolopoulos, V., Lofthouse, S., Pietersz, G.A., Popovski, V., Osinski, C. and McKenzie, I.F.C. Austin Hospital Research Week. Melbourne, Australia, October 1996. The induction of cytotoxic T lymphocyte responses by conjugation of antigen to mannan

Lees, C.J., Apostolopoulos, V., Ong, C.S., Xing, P.X., Acres, B., Ramshaw, I., Matthaei, K. and McKenzie, I.F.C. 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, December 1996. Directing the T1/T2 immunogenicity pathways of a mucin-1 based vaccine with cytokines

Ho, D., Pietersz, G.A., Apostolopoulos, V., Popovski, V., Osinski, C. and McKenzie, I.F.C. 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, Dec. 1996. Use of mannan-peptide conjugates in vaccine studies

Pietersz, G.A., Li, W., Apostolopoulos, V., Toohey, B., Osinski, C. and McKenzie, I.F.C. 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, Dec. 1996. Immune responses to natural mucin and human MUC1 tandem repeat

Stambas, J., Apostolopoulos, V., Pietersz, G.A., McKenzie, I.F.C. and Cheers, C. 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, Dec. 1996. Induction of a T1 response by proteins linked to mannan 

Karanikas, V., Hwang, L., Pearson, J., Apostolopoulos, V., Xing, P.X., Ong, C.S., Pietersz, G.A. and McKenzie, I.F.C. 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, December 1996. Immune responses in patients with breast, pancreatic and ovarian adenocarcinomas immunised with mannan-MUC1 fusion protein

Apostolopoulos, V., Chelvanayagam, G. and McKenzie, I.F.C. Antigen Processing and Presentation Workshop - 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, Dec. 1996. The induction of CTL using M-FP: detection of multiple MUC1 epitopes which associate with Class I molecules in a novel manner 

Apostolopoulos, V., Karanikas, V., Sherman, L., Chelvanayagam, G. and McKenzie, I.F.C. Antigen Processing and Presentation Workshop - 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, December 1996. Induction of anti-MUC1 CTL presented by HLA-A2.1 molecules

Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. Antigen Processing and Presentation Workshop - 1st Congress of The Federation of Immunological Societies of Asia-Oceana hosted by The Australasian Society for Immunology Inc., Adelaide, Australia, December 1996. Adoptive immunotherapy using macrophage/dendritic cells stimulated in vitro induce CTL in vivo

Apostolopoulos, V., Pietersz, G.A., Lees. C.J., Karanikas, V. and McKenzie, I.F.C. 1st Daydream Island Tumour Immunology Workshop, Queensland, Australia, December 1996. Immunogenicity of mannan-MUC1 peptides: Novel Class I peptide presentation and strategies to enhance the immunogenicity

Apostolopoulos, V., Chelvanayagam, G., Lofthouse, S., Popovski, V. and IFC McKenzie. The 5th annual conference of the immunology group of Victoria - New directions in immunological research, Mt Buffalo, VIC, Australia, March 1997. Mannan-MUC1 peptides presented in a novel class I manner and a MUC1 mimic induces functional CTLs

Lees. C.J., Apostolopoulos, V., Ong, C.S., Xing, P.X., Acres, B., Ramshaw, I., Matthaei, K. and McKenzie, I.F.C. The 5th annual conference of the immunology group of Victoria - New directions in immunological research, Mt Buffalo, VIC, Australia, March 1997. (Oral presentation, best presentation, Book Prize to CJ Lees).  Immunotherapy with Mucin-1 and Cytokines

Karanikas, V., Hwang, L., Pearson, J., Ong, C.S.,  Apostolopoulos, V., Vaughan, H., Xing, P.X., Jamieson, G., Pietersz, G.A., Tait, B., Broadbent, R., Thyme, G. and McKenzie, I.F.C. The 5th annual conference of the immunology group of Victoria - New directions in immunological research, Mt Buffalo, VIC, Australia, March 1997. Antibody and T cell responses of patients with adenocarcinoma immunised with mannan-MUC1 fusion protein.

Apostolopoulos, V., Osinski, C and McKenzie, I.F.C. 4th World Conference on Melanoma, Sydney, Australia, June 1997. CTL induction to melanoma peptides by targeting the mannose receptor

Karanikas, V., Pearson, J., Gunawardana, D.,  Apostolopoulos, V., Ong, C.S., Thyme, G. and McKenzie, I.F.C. Austin Hospital Research Week. Melbourne, Australia, October 1997. Phase I trial in patients with breast and colon cancer immunised with mannan-MUC1 fusion protein and cyclophosphamide

Lees. C.J., Apostolopoulos, V., Ong, C.S., Acres, B. and McKenzie, I.F.C. Austin Hospital Research Week. Melbourne, Australia, October 1997. Cytokines enhance the immunogenicity of Mucin-1 (MUC1) based tumour immunotherapy

Apostolopoulos, V., Sandrin, M.S., Popovski, V., Osinski, C. and McKenzie, I.F.C. Symposium: 27th Annual Scientific meeting, The Australasian Society for Immunology Inc., Univ. of Western Australia, Perth, WA, Australia, December 1997. Mimics and cross reactions of relevance to tumour immunotherapy

Apostolopoulos, V., Sandrin, M.S. and McKenzie, I.F.C. 2nd Tumour Immunology Workshop, Perth, Australia, December 1997. Mimics and cross reactions of relevance to tumour immunotherapy

Apostolopoulos, V., Pietersz, G., Chelvanayagam, G. and McKenzie, I.F.C. 2nd Tumour Immunology Workshop, Perth, Australia, December 1997. Aldehyde-mannose preferentially localises to Class I pathway and Unusual features of MUC1 peptide presentation.

Lees, C.J., Apostolopoulos, V. and McKenzie, I.F.C. 27th Annual Scientific meeting, The Australasian Society for Immunology Inc., Univ. of Western Australia, Perth, WA, Australia, December 1997. Both T1 and T2-type cytokines are induced in the same environment by either CD4 or CD8 T cells

Lees, C.J., Apostolopoulos, V. and McKenzie, I.F.C. 2nd Tumour Immunology Workshop, Perth, Australia, December 1997. In vivo evidence for an absolute requirement for class I on the surface of tumour cells for CTL tumour recognition

Pietersz, G., Popovski, V., Caruana, J., Apostolopoulos, V. and McKenzie, I.F.C. 27th Annual Scientific meeting, The Australasian Society for Immunology Inc., Univ. of Western Australia, Perth, WA, Australia, December 1997. Parameters for using mannan-MUC1 fusion protein (M-FP) to induce cellular immunity

McKenzie, I.F.C., Apostolopoulos, V. and Pietersz, G. Keystone Meeting - Taos, New Mexico, Feb. 1998. Oxidized Mannose Delivers Peptides Into the Class I MHC Presentation Pathway

Apostolopoulos, V., Sandrin M.S. and McKenzie, I.F.C. International Symposium. Advances in Peptide, Protein and Nucleic Acid, Vaccine Strategies. Oxford, England, July1998. Mimics and cross reactions of relevance to tumour immunotherapy

Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. International Symposium. Advances in Peptide, Protein and Nucleic Acid, Vaccine Strategies. Oxford, England, July 1998. Aldehyde - mannan antigen complexes preferentially target the MHC Class I pathway

Apostolopoulos, V., Chelvanayagam, G., Pietersz, G.A and McKenzie, I.F.C. 5th International Workshop on Carcinoma-Associated Mucins, Cambridge, England, July 1998. The mode of intracellular transport and trafficking of MUC1 peptides

Apostolopoulos, V., Chelvanayagam, G., Sandrin M.S., Karanikas, V. and McKenzie, I.F.C. 5th International Workshop on Carcinoma-Associated Mucins, Cambridge, England, July 1998. Cross reactions and mimics of human MUC1

Karanikas, V., Pearson, J., Ong, C.S., Apostolopoulos, V., Gunawardana, D., Thyme, G. and McKenzie, I.F.C. 5th International Workshop on Carcinoma-Associated Mucins, Cambridge, England, July 1998. Phase I trials in patients with adenocarcinoma immunised with cyclophosphamide and mannan-MUC1 fusion protein

Karanikas, V., Pearson, J., Apostolopoulos, V. and McKenzie, I.F.C. 5th International Workshop on Carcinoma-Associated Mucins, Cambridge, England, July 1998. Presentation of Tumour antigens by mannose receptor positive dendritic and macrophage cells

Pietersz, G., Li, W., Osinski, C., Apostolopoulos, V. and McKenzie, I.F.C. 5th International Workshop on Carcinoma-Associated Mucins, Cambridge, England, July 1998. Immune responses to non-variable number of tandem repeat (VNTR) sequences of human mucin 1 (MUC1) in mice

Apostolopoulos, V., Stratmann, T., Kang, A. and Teyton, L. 24th Annual Conference of the La Jolla Immunologists. The Salk Institute, La Jolla CA USA, 1998. Determination of MHC class II T cell epitopes with peptide libraries

Stratmann, T., Apostolopoulos, V., Scott, C., Kang, A. and Teyton, L. 24th Annual Conference of the La Jolla Immunologists. The Salk Institute, La Jolla CA USA, 1998. Functional characterisation of a recombinant form of the murine MHC class II molecule IAg7

Apostolopoulos, V., Pietersz, G.A. McKenzie, I. 90th American Association for Cancer Research. Philadelphia, PA USA, 1999. Preclinical and clinical studies using mannan-MUC1

Apostolopoulos, V., McKenzie, I.F.C., Teyton, L., Chelvanayagam, G., and Wilson, I.A. 90th American Association for Cancer Research. Philadelphia, PA USA, 1999. Unusual and novel features of peptide binding to MHC Class I molecules

Gong, J., Apostolopoulos, V., Chen, D., Koido, S., Rowse, G.J., Gendler, S.J., McKenzie, I.F.C., and Kufe, D. 90th American Association for Cancer Research. Philadelphia, PA USA, 1999. Identification of MUC1-specific CD8+ T cells in reversal of tolerance to MUC1 transgenic mice

Apostolopoulos, V., McKenzie, I., Huang, M., Teyton, L., Chelvanayagam, G. Wilson, I.A. West Coast Protein Crystallography Workshop. Asilomar Conference Center, Pacific Grove, CA USA, 1999. Unusual and novel features of peptide binding to MHC Class I molecules

Apostolopoulos, V., Yu, M., McKenzie, I.F.C., Teyton, L. and Wilson, I.A. Keystone Symposia on Molecular and Cellular Biology. Cellular Immunity and Immunotherapy of Cancer. Santa Fe, New Mexico USA. 2000. Novel features of peptide binding to MHC Class I molecules

McKenzie, I.F.C., Apostolopoulos, V., Yu, M. and Wilson, I.A. Transplantation Society of Australia and NZ. Rome, Italy, 2000. Structural features of peptides binding MHC class I molecules.

McKenzie, I.F.C., Apostolopoulos, V., Yu, M. and Wilson, I.A. 18th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand. Canberra, Australia, 2000. Structural features of peptides binding MHC class I molecules. 

Apostolopoulos, V. Drug Discovery and Design Conference. University of Patras, Departments of Chemistry and Pharmacology. Patras, Greece. 2000. Structural implications for the design of molecular vaccines

Stratmann, T., Apostolopoulos, V., Mallet-Designe, V., Scott, C., Wilson, I.A., Kang, A. and Teyton, L. 39th Midwinter Immunology Conference, Asilomar Conference Center, Pacific Grove, CA USA, 2000. I-Ag7 and I-Ad side by side - what is the difference that leads to diabetes?

McKenzie, I. and Apostolopoulos, V. 5th International Workshop on Carcinoma-Associated Mucins, Cambridge, England, 2000. Lessons learned from MUC1 immunisation of mice and humans making it a potential target for immunotherapy.

McKenzie, I.F.C., Apostolopoulos, V., Yu, M. and Wilson, I.A. 30th Annual Scientific meeting, The Australian Society of Immunology, Sydney, Australia, 2000. Structural features of peptides binding MHC class I molecules.

Apostolopoulos, V., Yu, M., Corper, A., McKenzie, I., Teyton, L. Wilson, I.A. 26th Annual Conference of La Jolla Immunologists. The Salk Institute, La Jolla CA USA, 2000. Crystal structure of an immunogenic peptide-MHC complex with a non-canonical low affinity peptide

Apostolopoulos, V., Yu, M., Corper, A., Wenjun, L., Pietersz, GA., Teyton, L., McKenzie, I.F.C. and Wilson, I.A. 4th Annual Fall Research Symposium of the Society of Fellows. The Scripps Research Institute, La Jolla CA USA, 2000. Crystal structure of an immunogenic peptide-MHC complex with a non-canonical low affinity peptide

Apostolopoulos, V., Yu, M., Pietersz, GA., Wenjun, L., Teyton, L., McKenzie, I.F.C. and Wilson, I.A. American Association of Immunologists, Annual Meeting. Orlando, FL USA, 2001. Crystal Structures of Non Canonical Binding Peptides: Low Affinity Vs High Affinity Binding

Apostolopoulos, V., Yu, M., Corper, A., Pietersz, GA., Wenjun, L., Teyton, L., McKenzie, I.F.C. and Wilson, I.A. West Coast Protein Crystallography Workshop. Asilomar Conference Center, Pacific Grove, CA USA, March 2001. Crystal Structures of Non Canonical Binding Peptides: Low Affinity Vs High Affinity Binding

Apostolopoulos, V., Yu, M., Corper, A., Pietersz, GA., Wenjun, L., Teyton, L., McKenzie, I.F.C. and Wilson, I.A. The 31st Annual Meeting, Australasian Society for Immunology, Canberra, NSW, Australia, December 2001. Crystal structure of a non-canonical high affinity peptide complexed with MHC class I: an alternative use of anchor pockets

Apostolopoulos, V., Yu, M., Corper, A., Pietersz, GA., Wenjun, L., Teyton, L., McKenzie, I.F.C. and Wilson, I.A. Tumour Immunology Workshop, Canberra, NSW Australia, Dec. 2001. Crystal structure of a non-canonical low affinity peptide complexed with MHC class I: a new approach for vaccine design.

Loveland, B.E., Zhao, A., Bardsley, B., Apostolopoulos, V., Osinski, C., Plebanski, M., Mitchell, P. and McKenzie, I.F.C. The 31st Annual Meeting, Australasian Society for Immunology, Canberra, NSW Australia, December 2001. In vitro expansion and vaccine pulsing of monocyte-derived human dendritic cells for adenocarcinoma immunotherapy

Desai, J., Mitchell, P.L., Loveland, B.E., Bardsley, B., White, S., Zhao, A., Apostolopoulos, V., Osinski, C., Xing, P-X., Smith, C., MacDonald, C. and McKenzie, I.F.C. American Association for Clinical Oncology, USA, May 2002. A Phase I trial of dendritic cells pulsed with MUC1 peptide in patients with solid tumours.

Vaccine-pulsed monocyte-derived human dendritic cells induce strong IFN-gamma responses in MUC1+ cancer patients.

Apostolopoulos, V., Yu, M., Corper, A., Pietersz, GA., Wenjun, L., Teyton, L., McKenzie, I.F.C. and Wilson, I.A. Austin and Repatriation Medical Centre, 10th Annual Research Week, October 2002. Crystal structure of a non-canonical low affinity peptide complexed with MHC class I: a new approach for vaccine design

Apostolopoulos, V. Drug Discovery and Design Conference. University of Patras, Departments of Chemistry and Pharmacology. Patras, Greece. March 2002
i) Crystal structures of non-canonical low and high affinity peptide complexes with MHC class I: a
novel use of alternative anchors
ii) Update on clinical trials in adenocarcinoma patients immunised with mannan-MUC1

Apostolopoulos, V., Pietersz, GA. and McKenzie, I.F.C. DAMD Era of Hope Congress, New York, NY USA. October 2002. Vaccine development against novel breast cancer antigens.

Apostolopoulos, V., Zhao, A., Pietersz, G.A., Xing, P-X., Osinski, C., Bardsley, B., Mitchell, P.L., McKenzie, I.F.C., Loveland, B.E. Basic Aspects of Tumour Immunology, Keystone Resort, Keystone, Colorado, USA, February 2003. Vaccine-pulsed monocyte-derived human dendritic cells induce strong IFN-gamma responses in MUC1+ cancer patients.

Son, H-Y., Kim, S-H., Lee, M-J., Kim, H-J., Chung, D-S., Park, S-O., Woo, J-K., Huh, J-W, Apostolopoulos, V., Kim, C-W. 94th American Association for Cancer Research. Ontario, Toronto, Canada, 2003. Oxidative mannan as a useful adjuvant for T/Tn cancer vaccine.

McKenzie, I.F.C., Apostolopoulos, V., Xing, P.X., Pietersz, G.A., Loveland, B.E., International Association for Breast Cancer. Sacramento, CA USA, November 2003. Cancer Immunotherapy

McKenzie, I.F.C., Apostolopoulos, V., Xing, P.X., Pietersz, G.A., Loveland, B.E., The 33rd Annual Meeting, Australasian Society for Immunology, Perth, WA Australia, December 2003. Cancer Immunotherapy

Apostolopoulos, V., Yu, M., McKenzie, I.F.C. and Wilson, I.A. Vaccines and Immunotherapeutics, Keystone Resort, Keystone, Colorado, USA, January 2004. Novel modes of peptide binding to MHC class I: a new approach to peptide based vaccine design

Apostolopoulos, V. 5th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Dept of Chemistry and Pharmacology. Patras, Greece. March 2004. Novel modes of peptide binding to MHC class I: A new approach to peptide based vaccine design

Apostolopoulos, V. 5th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Dept of Chemistry and Pharmacology. Patras, Greece. March 2004. Clinical trials in adenocarcinoma patients immunised with mannan-MUC1

Vassilaros, S., McKenzie, I.F.C. and Apostolopoulos, V. Drug Discovery and Design Conference. University of Patras, Departments of Chemistry and Pharmacology. Patras, Greece. March 2004. Clinical evaluation of phase III clinical trial in early stage breast cancer patients after mannan-MUC1 immunisation

Plebanski, M., Flanagan, K., Reece, W.H.H., Pinder, M., Marsh, K., Hill, A.V.S. and Apostolopoulos, V. Howard Hughes Medical Institute Conference, Talinn, Estonia, June 2004. T cell epitope mapping in endemic populations: are we seeing the whole picture?

Pouniotis, D.S., Apostolopoulos, V*. and McDonald, C.F*. Thoracic Society of Australia and New Zealand (TSANZ) – Victorian Branch Meeting. Werribee, VIC, Australia, November 2004. (* equal contribution). Oral presentation, best Scientific Award Prize to DS Pouniotis. Alveolar macrophage function is altered in patients with primary lung cancer

Apostolopoulos, V. Tumour Immunity Symposium. Seoul National University College of Medicine, Korea, June 2004. T cell epitope mapping in endemic populations: are we seeing the whole picture?

Maxwell, T., Sheng, K.C., Prato, S., Pinzon-Charry-A., Lincoln, D., Pietersz, G.A., Apostolopoulos, V., and Lopez, J.A. The 34th Annual Meeting, Australasian Society for Immunology, Adelaide, SA, Australia, December 2004. Mannan derivatives induce phenotypic and functional maturation of human monocyte-derived dendritic cells

Pouniotis, D.S., Pietersz, G.A., van Maanen, P.J., Andriessen, R.W., Lodding, J., Xing, P.X., McKenzie, I.F.C., Loveland, B.E. and Apostolopoulos, V. Tumour Immunology Workshop, Adelaide, SA, Australia, December 2004. Delivery of tumour antigens and cytotoxic T cell epitopes using a membrane translocating peptide induces cellular and protective immune responses. 

Apostolopoulos, V., Lazoura, E., Lodding, J., McKenzie, I. Wilson, I.A. Tumor Immunology Workshop. Adelaide, SA, Australia, December 2004. Structural and immunological analysis of non-canonical peptide complexes with MHC class I: new approaches to vaccine design. 

Pouniotis, D.S., Apostolopoulos, V*. and McDonald, C.F*. Annual meeting of the Thoracic Society of Australia and New Zealand. Perth, WA, Australia, March 2005. (* equal contribution). Alveolar macrophage function is altered in patients with primary lung cancer 

Katsara, M., Apostolopoulos, V*., Tselios, T., Deraos, S. and Matsoukas, J*. 6th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Departments of Chemistry and Pharmacology. Patras, Greece. March 2005. (* equal contribution). Myelin Basic Protein (MBP) and Proteolipid Protein (PLP) Peptides (cyclic and linear, agonist and antagonist): Immune Responses in animal models for Multiple Sclerosis

Apostolopoulos, V. Seoul National University College of Medicine, Seoul, Korea, April 2005. Novel modes of peptide binding to MHC class I: Implications in peptide-based vaccine design

Apostolopoulos, V. 2nd Tumour Immunity Symposium. Seoul National University College of Medicine, Korea. April 2005. MUC1 cancer Vaccine: From animal models to human clinical trials

Apostolopoulos, V., Lazoura, E., Lodding, J., McKenzie, I.F.C and Wilson I.A. Mucins in Health and Disease (8th International Workshop on Carcinoma-Associated Mucins). Cambridge, England, July 2005. Structural and immunological analysis of non-canonical peptide complexes with MHC class I: new approaches to vaccine design

Pietersz, G.A., Pouniotis, D.S., van Maanen, P.J., Andriessen, R.W., Lodding, J., Xing, P.X., McKenzie, I.F.C and Apostolopoulos, V. Mucins in Health and Disease (8th International Workshop on Carcinoma-Associated Mucins). Cambridge, England, July 2005. Immunological delivery of MUC1 (VNTR and non-VNTR) proteins and peptides to DC, using a membrane translocating peptide, induces cellular and protective immune responses

Apostolopoulos, V., Tang, C.K., Lodding, J., McKenzie, I.F.C. and Pietersz, G.A. Mucins in Health and Disease (8th International Workshop on Carcinoma-Associated Mucins). Cambridge, England, July 2005. Novel non-viral receptor mediated gene transfer ligands for cancer immunotherapy: oxidised and reduced mannan

Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. Mucins in Health and Disease (8th International Workshop on Carcinoma-Associated Mucins). Cambridge, England, July 2005. Clinical trials in adenocarcinoma patients immunized with mannan-MUC1

Katsara, M., Tselios, T., Deraos, S. and Matsoukas, J and Apostolopoulos, V. Peptide Users group, Autumn peptide Symposium. Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, VIC Australia, April 2005. MBP and PLP Peptides (cyclic and linear, agonist and antagonist): Immune Responses in animal models for Multiple Sclerosis

Pouniotis, D.S., van Maanen, P.J., Andriessen, R.W., Lodding, J., Xing, P., McKenzie, I., Loveland, B. Apostolopoulos, V. Cancer Vaccines/Adjuvants/Delivery for the next decade. Pestana Palace Hotel, Lisbon, Portugal, September 2005. Delivery of tumour antigens and cytotoxic T cell epitopes using a membrane translocating peptide induces cellular and protective immune responses. 

Katsara M,, Tselios T., Deraos S., Deraos G., Matsoukas J. and Apostolopoulos, V. Austin Health Research Week, Heidelberg, VIC Australia, October 2005. Myelin Basic Protein (MBP) and Proteolipid Protein (PLP) Peptides (linear and cyclic, agonist and antagonist): Immunomodulating Therapeutic Approaches for Multiple Sclerosis

Tang, C.K., Pietersz, G.A., Lodding, J., Minigo, G., Pouniotis, D., Plebanski, M., McKenzie, I.F.C. and Apostolopoulos, V. Austin Health Research Week, Heidelberg, VIC Australia, October 2005. Novel non-viral gene delivery vectors for cancer immunotherapy: oxidised and reduced mannan

Sheng, K-C., Pietersz, G.A., Pouniotis, D., Wright, M.D and Apostolopoulos, V. Austin Health Research Week, Heidelberg, VIC Australia, October 2005. Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells

Pouniotis, D.S., Pietersz, G.A and Apostolopoulos, V. Brisbane Immunology Group. Gold Coast, QLD Australia, August 2005. Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses

Katsara M,, Tselios T., Deraos S., Deraos G., Matsoukas J. and Apostolopoulos, V. Alfred Medical Research Week, Melbourne VIC Australia, October 2005. Effect of myelin basic protein (MBP) and Proteolipid protein (PLP) peptides (linear and cyclic) using CFA or conjugated to reduced mannan in animal models for Multiple Sclerosis.

Tang, C.K., Pietersz, G.A., Lodding, J., Minigo, G., Pouniotis, D., Plebanski, M., McKenzie, I.F.C. and Apostolopoulos, V. Alfred Medical Research Week, Melbourne VIC Australia, October 2005. Novel non-viral gene delivery vectors for cancer immunotherapy: oxidised and reduced mannan

Sheng, K-C., Pietersz, G.A., Pouniotis, D., Wright, M.D and Apostolopoulos, V. Alfred Medical Research Week, Melbourne VIC Australia, October 2005. Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells

Pouniotis, D.S., Pietersz, G.A and Apostolopoulos, V. Alfred Medical Research Week, Melbourne VIC Australia, October 2005. Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses

Gartlan, K.H., Nastovska, R., Van Spriel, A., Sheng, K.C., Robb, G., Pietersz, G.A., Apostolopoulos, V. and Wright, M.D. Alfred Medical Research Week, Melbourne VIC Australia, October 2005. The Immune Function of mice deficient for tetraspanin proteins CD37, Tssc6. 

Katsara, M., Deraos, G., Tselios, T., Deraos, S. and Matsoukas, J and Apostolopoulos, V. Peptide Users group, Spring peptide Symposium. VIC Australia, October 2005. Design and synthesis of novel linear and cyclic analogues based on myelin basic protein MBP83-99 epitope: Immune responses in animal models for multiple sclerosis

Apostolopoulos, V,, Lodding, J. and Lazoura, E. 35th Australian Society for Immunology. Melbourne, Australia. December 2005. New modes of peptide binding to MHC molecules.

Katsara M,, Tselios T., Deraos S., Deraos G., Matsoukas J. and Apostolopoulos, V. 35th Australasian Society for Immunology. Melbourne, Australia, December 2005. Myelin Basic Protein (MBP) and Proteolipid Protein (PLP) Peptides (linear and cyclic) and immune responses in animal models. Therapeutic Approaches for Multiple Sclerosis

Tang, CK., Lodding, J., Minigo, G., McKenzie, I., Pouniotis, D., Scholzen, A., Plebanski, M., Pietersz, G. Apostolopoulos, V. 35th Australian Society for Immunology. Melbourne Australia Dec 2005. Oxidised/Reduced mannan as receptor mediated gene delivery vehicles

Sheng, KC., Pouniotis, DS., Wright, MD, Tang, CK, Pietersz, GA. and Apostolopoulos, V. 35th Australasian Society for Immunology. Melbourne, Australia, December 2005. Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells

Pouniotis, D.S., Apostolopoulos, V. and Pietersz, G.A. 35th Australasian Society for Immunology. Melbourne, Dec 2005. Mechanism of uptake, processing and class I/II presentation of protein and peptides linked to membrane translocating peptides. 

Gartlan, K.H., Nastovska, R., van Spriel, A., Sheng, K.C., Lazoura, E., Robb, G., Pietersz, G.A., Apostolopoulos, V. and Wright, M.D. 35th Australasian Society for Immunology. Melbourne, Australia, December 2005. The Immune Function of mice deficient in expression of the tetraspanin genes CD37 and Tssc6. 

Maxwell, T., Tang, C., Forster, T., Pietersz, G.A., Apostolopoulos V. and Lopez, J.A. 35th Australasian Society for Immunology. Melbourne, Australia, December 2005. Efficient antigen delivery into dendritic cell by transfection of mRNA conjugated with oxidised-mannan and polyethylenimine. 

Pietersz, G,A., Esparon, S., Proudfoot, O., Lodding, J., Singh, Y., Meanger, J., Plebanski, M., Hogarth, M., Coulson, B., Apostolopoulos, V. and Cheers, C. 35th Australasian Society for Immunology. Melbourne, Australia, December 2005. Development of mucosal vaccines for respiratory syncytial virus, bacillus anthracis and rotavirus based on oxidised mannan.

Pietersz, G,A., Tang, C.K., Sheng, K,C., Maxwell, T., Pouniotis, D.S., Lodding, J., Minigo, G., Plebanski, M., McKenzie, I.F.C., Lopez, A. and Apostolopoulos, V. Tumour Immunology Workshop. Melbourne, Australia, December 2005. Mannan-mediated delivery of protein, DNA and RNA to antigen presenting cells. 

Wright, M.D., van Spriel, A.B., Gartlan, K., Nastovska, R., Sofi, M., Daunt, C., Sheng, KC., Apostolopoulos V., Pietersz, G.A., Light, A. and Tarlinton, D. 35th Australasian Society for Immunology. Melbourne, Australia, December 2005. The role of the tetraspanin CD37 in T and B cell responses. 

Lazoura, E., Lodding, J., Farrugia, W., Ramsland, P.A., Stevens, J., Wilson, I.A., Pietersz, G.A and Apostolopoulos, V. 7th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Dept of Chemistry and Pharmacology. Patras, Greece. March 2006. Crystal structure of the anchor modified non-canonical tumour associated MUC1-8 peptide, showing enhanced MHC class I binding and immune responses, in complex with H-2Kb.

Katsara, M., Deraos, G., Tselios, T., Deraos, S., Matsoukas, J and Apostolopoulos, V. 7th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Departments of Chemistry and Pharmacology. Patras, Greece. March 2006. Immune responses of (MBP83-99) analogues (alone or conjugated with mannan) in SJL/J mice.

Pietersz, G.A., Pouniotis, D.S. and Apostolopoulos, V. 7th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Departments of Chemistry and Pharmacology. Patras, Greece. March 2006. Novel Methods of Antigen Delivery for Vaccines

Vassilaros, S., McKenzie, I.F.C., Pietersz, G.A. and Apostolopoulos, V. 7th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Departments of Chemistry and Pharmacology. Patras, Greece. March 2006. Adjuvant therapy with or without fusion protein mannan-MUC1 in stage II breast cancer-phase III.

McKenzie, I.F.C., Lodding, J., Apostolopoulos, V. , Pietersz, G.A., Esparon, S., Stinear, T., Pidot, S., Hayman, J., Small, P and Johnson, P. ThymOz conference. Heron Island, Qld Australia. April 2006. Mechanisms and treatment of M. Ulcerans ulceration

Katsara, M., Tselios, T., Deraos, S., Deraos, G., Matsoukas, J and Apostolopoulos, V. Bioactive peptides Conference. Athens, Greece. May 2006. Rational design and synthesis of myelin basic protein (MBP) and proteolipid protein (PLP) peptides: Immunotherapy for MS

Apostolopoulos, V., Pietersz, G.A., Tsibanis, A., Tsikkinis, A., Drakaki, H., Loveland, B.E., Piddlesden, S.J., Plebanski, M., Pouniotis, D.S., Alexis, M.N., McKenzie, I.F.C. and Vassilaros, S. 1st Australasian vaccines and immunotherapeutics development meeting. Bio21Institute, VIC Australia. May 2006. Pilot Phase III immunotherapy study in early stage breast cancer patients using oxidized mannan-MUC1.

Sheng, K.C., Kalkanidis, M., Pietersz, G.A., Pouniotis, D.S., Tang, C.K., Wright, M.D., Lazoura, E. and Apostolopoulos, V. 1st Australasian vaccines and immunotherapeutics development meeting. Bio21 Institute, VIC Australia. May 2006. Mannose residues facilitate both antigen presentation and functional maturation of mouse dendritic cells.

Katsara, M., Tselios, T., Deraos, S., Deraos, G., Matsoukas, J and Apostolopoulos, V. 1st Australasian vaccines and immunotherapeutics development meeting. Bio21 Molecular Science and Biotechnology Institute, VIC Australia. May 2006. Myelin basic protein (MBP) and proteolipid protein (PLP) peptides (linear and cyclic) and immune responses in SJL mice: Immunotherapeutic approaches for MS

Tang, C.K., Lodding, J., Minigo, G., McKenzie, I.F.C., Scholzen, A., Pouniotis, D.S., Plebanski, M., Pietersz, G.A. and Apostolopoulos, V. 1st Australasian vaccines and immunotherapeutics development meeting. Bio21 Molecular Science and Biotechnology Institute, VIC Australia. May 2006. Oxidised and reduced mannan as receptor mediated gene delivery vehicles

Lazoura, E., Lodding, J., Farrugia, W., Ramsland, P.A., Stevens, J., Wilson, I.A., Pietersz, G.A and Apostolopoulos, V. 1st Australasian vaccines and immunotherapeutics development meeting. Bio21 Molecular Science and Biotechnology Institute, VIC Australia. May 2006. Anchor modification of non-canonical tumour associated MUC1-8 peptide, with enhanced MHC class I binding and immune responses – crystal structure and biological data.

Pietersz, G.A., Pouniotis, D.S. and Apostolopoulos, V. 1st Australasian vaccines and immunotherapeutics development meeting. Bio21 Institute, VIC Australia. May 2006. Novel Methods of Antigen Delivery for Vaccines

Gartlan, K., van Spriel, A.B., Nastovska, R., Sofi, M., Sheng, K.C., Robb, L., Pietersz, G.A., Apostolopoulos V. and Wright, M.D. 4th FASEB – Membrane organisation by tetraspanins and small multi-transmembrane proteins. Tucson, AZ, USA. July 2006. Immune function in mice deficient for the expression of both tetraspanins CD37 and Tssc6.

van Spriel, A.B., Gartlan, K., Sheng, K.C., Sofi, M., Daunt, C., Robb, L., Apostolopoulos V. and Wright, M.D. 4th FASEB – Membrane organisation by tetraspanins and small multi-transmembrane proteins. Tucson, AZ, USA. July 2006. Dendritic cell function in mice lacking CD37, Tssc6 and CD151.

Pouniotis, D., Pietersz, G.A. and Apostolopoulos, V. The 2nd International conference on Modern Vaccines adjuvants nd delivery systems. The Royal Society of Medicine, London, UK. September 2006. Penetratin linked to proteins or peptides induce cellular and protective immune responses via diverse processing mechanisms

Pouniotis, D., Pietersz, G. Apostolopoulos, V. 1st joint meeting of European National Societies of Immunology. Paris, France. September 2006. Penetratin linked to proteins or peptides induce cellular and protective immune responses via diverse processing mechanisms

Maxwell, T., Tang, C.K., Forster, T., Pietersz, G.A., Apostolopoulos V. and Lopez, J.A. 1st joint meeting of European National Societies of Immunology (ECI). Paris, France. September 2006. A novel dendritic cell RNA delivery strategy for cancer immunotherapy

Maxwell, T., Tang, C.K., Forster, T., Pietersz, G.A., Apostolopoulos V. and Lopez, J.A. 9th International conference on dendritic cells (DC2006), Edinburgh, Scotland. September 2006. A novel dendritic cell RNA delivery strategy for cancer immunotherapy

Deraos G., Katsara M,, Tselios T., Deraos S., Apostolopoulos, V. and Matsoukas J. Design and synthesis of Myelin Basic Protein (MBP) linear and cyclic peptide analogues complexed with mannan: Effects in cytokine production. 29th European Peptide Symposium, Gdansk, Poland. September 2006.

Sheng, K.C., Kalkanidis, M., Wright, M.D., Esparon, S., Pouniotis, D.S., Tang, C.K, Pietersz, G.A. and Apostolopoulos, V. 13th Annual IgV Conference, Beechworth, VIC Australia. October 2006. Polymannose potentiates antigenicity via enhanced antigen presentation and functional maturation of mouse dendritic cells.

Katsara, M., Deraos, G., Matsoukas, J and Apostolopoulos, V. 13th IgV Conference, Beechworth, VIC Australia. October 2006. Immune responses to MBP83-99 (linear and cyclic) peptides and its analogues in SJL/J mice. 

Tang, CK., Lodding, J., Minigo, G., McKenzie, IFC., Pouniotis, DS., Pietersz, G.A. Apostolopoulos, V. 13th Annual IgV Conference, Beechworth, VIC Australia. October 2006. Immunotherapy using mannan-DNA complexes

Gartlan, K., van Spriel, A., Nastovska, R., Sofi, M., Sheng, K.C., Robb, L., Pietersz, G., Apostolopoulos V., Wright, M.D. 13th IgV Conference. Beechworth, VIC Australia. Oct 2006. The immune function of mice deficient in both tetraspanins CD37 and Tssc6.

Katsara, M., Deraos, G., Matsoukas, J and Apostolopoulos, V. Alfred Medical Research Week, VIC Australia. October 2006. Immune responses to MBP83-99 (linear and cyclic) peptides and its analogues in SJL/J mice. 

Apostolopoulos, V., Pietersz, G.A., Tsibanis, A., Tsikkinis, A., Drakaki, H., Loveland, B.E., Piddlesden, S.J., Plebanski, M., Pouniotis, D.S., Alexis, M.N., McKenzie, I.F.C. and Vassilaros, S. 1st Australasian vaccines and immunotherapeutics development meeting. Bio21 Molecular Science and Biotechnology Institute, VIC Australia. May 2006. Human clinical trials: Oxidised mannan-MUC1 in Pilot Phase III immunotherapy study in early stage breast cancer patients

Tang, C.K., Sheng, KC., Lodding, J., Pietersz, G., Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Immunisation with mannan-poly-L-lysine complexed to MUC1 DNA induces specific and protective responses in vivo 

Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Non canonical peptide complexes with MHC class I or II: are we seeing the whole picture

Lodding, J., Lazoura, E., Farrugia, W., Ramsland, P.A., Stevens, J., Wilson, I.A., Pietersz, G.A. and Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Enhanced MHC class I binding and immune responses through anchor modification of the non-canonical tumour associated MUC1-8 peptides

Sheng, KC., Gartlan, K., Sofi, M., Moseley, G., Ashman, L., Pietersz, G.A., Wright, M.D. and Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Immunological function of tetraspanin CD151

Sheng, KC., Kalkanidis, M., Wright, M.D., Esparon, S., Pouniotis, D.S., Tang, C.K., Lazoura, E., Pietersz, G.A. and Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Polymannose potentiates antigenicity via enhanced antigen presentation and functional maturation of mouse dendritic cells

Katsara, M., Tselios, T., Matsoukas, J and Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Novel linear and cyclic GnRH analogues inhibit proliferation of the human tumour cell line MCF7 

Katsara, M., Deraos, G., Matsoukas, J and Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Rational altered peptide ligands of Myelin basic protein for immunotherapy of multiple sclerosis

Katsara, M., Deraos, S., Grigoriadis, N., Matsoukas, J and Apostolopoulos V. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. Suppression of chronic EAE using a novel cyclic peptide: immunological analysis 

Gartlan, K., Belz, G., Kyparissoudis, K., Nastovska, R., Robb, L., Pietersz, G.A., Apostolopoulos V., Godfrey, D.I. and Wright, M.D. 36th Australasian Society for Immunology. Auckland, New Zealand, December 2006. The tetraspanins CD37 and Tssc6 play a complimentary role in immune function.

Katsara, M., Deraos, G., Matsoukas, J. and Apostolopoulos, V. 8th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Departments of Chemistry and Pharmacology. Patras, Greece. March 2007. Immune responses to rational altered peptide ligands of myelin basic protein (linear and cyclic) in SJL mice

Apostolopoulos, V. 8th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Dept of Chemistry and Pharmacology. Patras, Greece. March 2007. Cancer immunotherapy: what have we learnt in the last 15 years

Vassilaros, S., Tsibanis, A., Tsikkinis, A., Drakaki, E., McKenzie, I. and Apostolopoulos, V. 8th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Departments of Chemistry and Pharmacology. Patras, Greece. March 2007. Follow-up of patients with early stage breast cancer of pilot phase III immunotherapy study

Dais, A., Friligou, I., Matsoukas, J., Apostolopoulos, V., Pietersz, G.A. and Gatos, D. 2nd Biotechnology Conference, Patras, Greece. April 2007. Design and synthesis of dendrimers using peptide analogues of MUC1 protein for the immunotherapy of cancer

Pietersz, G,A., Tang, C.K., Sheng, K,C., Maxwell, T., Pouniotis, D.S., Lodding, J., Minigo, G., Plebanski, M., McKenzie, I.F.C., Lopez, A. and Apostolopoulos, V. 9th International workshop on carcinoma-associated mucins. Mucins in health and disease. Cambridge, UK. July 2007. Mannan-mediated delivery of protein, DNA and RNA to antigen presenting cells. 

Apostolopoulos V. 9th International workshop on carcinoma-associated mucins. Mucins in health and disease. Cambridge, UK. July 2007. Non canonical peptide complexes with MHC class I or II: are we seeing the whole picture

Pouniotis, D.S., Pietersz, G.A. and Apostolopoulos V. 9th International workshop on carcinoma-associated mucins. Mucins in health and disease. Cambridge, UK. July 2007. Delivery of tumour associated antigens to antigen presenting cells using penetratin induces potent immune responses

McKenzie, I., Pietersz, G.A., Vassilaros, S and Apostolopoulos, V. Mucins in health and disease. Cambridge, UK. July 2007. Ten year follow up of patients with early stage breast cancer of pilot phase III immunotherapy study

Sheng, K.C., Kalkanidis, M., Pietersz, G.A and Apostolopoulos V. 5th International conference. DC2007 – Dendritic cell vaccination and other strategies to tip the balance of the immune system. Bamberg, Germany. July 2007. A novel mannose-based antigen delivery system potentiates immunogenicity via specific DC subtypes and TLR4 functionality

Pouniotis, D.S., Pietersz, G.A* and Apostolopoulos, V*. 5th International conference. DC2007 – Dendritic cell vaccination and other strategies to tip the balance of the immune system. Bamberg, Germany. July 2007. [*equal contribution]. Delivery of tumor antigens using a membrane translocating peptide to DC induces cellular and protective immune responses. 

Pouniotis, D.S., Pietersz, G.A. and Apostolopoulos V. The next Intracellular Delivery of Therapeutic Macromolecules: from Concept to Application in Grenoble September 19-21, 2007. Delivery of tumour associated antigens to antigen presenting cells using penetratin induces potent immune responses

Kalkanidis, M., Sheng, K.C., Apostolopoulos V. Pietersz, G. 5th International Dendrimer Symposium, Toulouse, September 2007. Immune responses and design of mannosylated dendrimers. 

Katsara, M., Deraos, G., Matsoukas, J. and Apostolopoulos, V. 4th International / 7th Australian Peptide Conference. Cairns, Australia. October 2007. T cell receptor altered peptide ligands of Myelin Basic Protein (MBP) and Proteolipid Protein (PLP) peptides (Linear and Cyclic) can modulate immune responses in SJL/J mice: Bioactive peptides for Multiple Sclerosis. 

Apostolopoulos V. 5th International workshop on antigen processing and presentation. Dunk Island, North Queensland, Australia. October 2007. Non canonical peptide complexes with MHC class I or II: are we seeing the whole picture

Katsara, M., Deraos, G., Matsoukas, J. and Apostolopoulos, V. Austin Health Research Week, Heidelberg, VIC, Australia. October 2007. A single or double TCR altered peptide ligands of Myelin Basic Protein (MBP) and Proteolipid Protein (PLP) (Linear and Cyclic) can modulate immune responses in SJL/J mice. 

Katsara, M., Tselios, T., Deraos, S., Deraos, G., Matsoukas, J. and Apostolopoulos, V. Peptide Users Group, Spring Symposium, VIC, Australia. October 2007. CD4 T cell responses to linear and cyclic mutated peptides of Myelin Basic Protein (MBP) and Proteolipid Protein (PLP) in SJL/J mice: Bioactive peptides for Multiple Sclerosis. 

Katsara, M., Deraos, G., Matsoukas, J. and Apostolopoulos, V. Progress in Multiple Sclerosis Research, WEHI, VIC, Australia. November 2007. A single or double TCR altered peptide ligands of Myelin Basic Protein (MBP) and Proteolipid Protein (PLP) (Linear and Cyclic) can modulate immune responses in SJL/J mice. 

Vassilaros, S., Tsibanis, A., Tsikkinis, A., Drakaki, E., McKenzie, I. and Apostolopoulos, V. San Antonio Breast Cancer Symposium, USA. December 2007. Ten year follow up of patients with early stage breast cancer of pilot phase III immunotherapy study

Apostolopoulos V. 5th International workshop on antigen processing and presentation. Dunk Island, Qld, Australia. Oct 2007. Non canonical peptide complexes with MHC class I or II: are we seeing the whole picture

Apostolopoulos V. 37th Australasian Society for Immunology. Sydney Australia, December 2007. Non canonical peptide complexes with MHC class I or II: are we seeing the whole picture

Apostolopoulos, V., McKenzie, I., Pietersz, G.A., Vassilaros, S. 37th Australasian Society for Immunology. Sydney Australia, December 2007. Ten year follow up of patients with early stage breast cancer of pilot phase III immunotherapy study

Gartlan, K., Belz, G., Kyparissoudis, K., Nastovska, R., Robb, L., Pietersz, G.A., Apostolopoulos V., Godfrey, D.I. and Wright, M.D. 2nd European Tetraspanin Symposium. Madrid, Spain, 2007. The tetraspanins CD37 and Tssc6 play a complimentary role in immune function.

Pouniotis, D.S., Brooks, N., Perret, J., Apostolopoulos, V., McDonald, C.F. The Thoracic society of Australia and New Zealand, Melbourne Convention Center, Australia, March, 2008. Blood monocytes function from patients with early diagnosed primary lung cancer

Perret, J., Apostolopoulos, V., McDonald, C.F., Pouniotis, D.S. The Thoracic society of Australia and New Zealand, Melbourne Convention Center, Australia, March, 2008. T helper-17 cell responses in chronic obstructive pulmonary disease: a pilot study

Katsara, M., Yuriev, E., Ramsland, P., Deraos, G., Tselios, T., Deraos, S., Matsoukas, J. and Apostolopoulos, V. 9th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Patras, Greece. March 2008. Linear/cyclic mutant analogues of self antigens (MBP and PLP) manipulate immune responses in mice

Apostolopoulos, V. 9th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Patras, Greece. March 2008. Peptide based vaccines: A structural and immunological perspective

Apostolopoulos, V. 2nd Australasian vaccines and immunotherapeutics development (AVID) meeting. Surfers Paradise, Qld Australia. May 2008. Non canonical peptide complexes with MHC class I or II in peptide based vaccines

Katsara, M., Yuriev, E., Ramsland, P.A., Deraos, G., Matsoukas, J. and Apostolopoulos, V. 2nd AVID meeting. Surfers Paradise, Qld Australia. May 2008. Development of a vaccine for multiple sclerosis

Sheng, K-C., Kalkanidis, M., Pouniotis, D.S., Wright, M.D., Pietersz, G.A. and Apostolopoulos, V. 2nd AVID meeting. Surfers Paradise, Qld Australia. May 2008. The adjuvanticity of a novel mannosylated antigen potentiates immune responses via toll-like receptor 4-modulated dendritic cell functionality.

Sheng, K-C., Kalkanidis, M., Pouniotis, D.S., Esparon, S., Tang, C.K., Apostolopoulos, V. and Pietersz, G.A. 2nd AVID meeting. Surfers Paradise, Qld Australia. May 2008. Mannosylated dendrimer modified antigens for immunotherapy.

Tang, C.K., Pietersz, G.A. Apostolopoulos, V. 2nd AVID meeting. Surfers Paradise, Australia. May 2008. Oxidised mannan potentiates DNA vaccine for use in cancer immunotherapy

Katsara, M., Yuriev, E., Ramsland, P., Deraos, G., Matsoukas, J. and Apostolopoulos, V. 30th European Peptide Symposium (30EPS), Helsinki, Finland. September 2008. Development of a vaccine against Multiple Sclerosis

Deraos, G., Chatzantoni, K., Matsoukas, M-T., Katsara, M., Tselios, T., Deraos, S., Papathanasopoulos, P., Vynios, D., Apostolopoulos, V., Mouzaki, A. Matsoukas, J. 30th European Peptide Symposium (30EPS), Helsinki, Finland. September 2008. Modifications of the myelin basic protein epitope MBP87-99 divert Th2 to Th1: immune responses in PBMC from MS patients

Immune cell function in endometrial cancer patients

Perret, J., McDonald, C., Pouniotis, D.S. and Apostolopoulos, V. Victorian Branch: Thoracic Society of Australia and New Zealand. Melbourne VIC October, 2008. Systemic cytokines in chronic obstructive pulmonary disease (COPD): A pilot study

Perret, J., Pouniotis, D.S., McDonald, C. and Apostolopoulos, V. Austin Medical Research Week, Austin Health. Melbourne VIC October, 2008. T helper-17 cell responses in chronic obstructive pulmonary disease (COPD): A pilot study

Day, S., Slaats, I., Sheng, K-C. and Apostolopoulos, V. 38th Australasian Society for Immunology. Canberra, ACT Australia, December 2008. Functional characterisation of Muc1 on murine lymphocytes

Sheng, K-C., Kalkanidis, M., Pouniotis, D.S., Esparon, S., Tang, C.K., Apostolopoulos, V. and Pietersz, G.A 38th Australasian Society for Immunology. Canberra, ACT Australia, December 2008. Mannosylated dendrimer-modified antigens for immunotherapy

Brooks, N., Pouniotis, D.S., Apostolopoulos, V. and Pietersz, G.A 38th Australasian Society for Immunology. Canberra, ACT Australia, December 2008. Delivery of multiple tumour epitopes by membrane translocating peptides

Tang, C.K., Apostolopoulos, V. and Pietersz, G.A 38th Australasian Society for Immunology. Canberra, ACT Australia, Dec 2008. Immune responses and mechanism of action induced by mannan mediated DNA vaccination

Sheng, K-C., Pietersz, G.A. and Apostolopoulos, V. Dendritic cells. Keystone Symposia, Fairmont Banff Springs, Banff, Alberta Canada. March 2009. The functionality of GM-CSF induced bone-marrow-derived dendritic cells is dependent on their developmental stage

Katsara, M., Matsoukas, J. and Apostolopoulos, V. 10th International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Patras, Greece. March 2009. Peptide mutants conjugated to reduced mannan shift immune responses in animal models

Sheng, K-C. and Apostolopoulos, V. TLROZ 2009. Pattern Recognition Receptors in Health and Disease, Surfers Paradise, Qld Australia. October 2009. The ROS level defines two functionally distinct DC stages of ex vivo dendritic cell development from mouse bone marrow

Katsara, M., Yuriev, E., Ramsland, P.A., Tselios, T., Deraos, G., Grigoriadis, N., Lourbopoulos, A., Matsoukas, J. and Apostolopoulos, V. 11th International Conference Medicinal Chemistry: Drug Discovery and Design, University of Patras, Patras, Greece, April 2010. Altered peptide ligands of myelin basic protein mutants conjugated to reduced mannan modulate immune responses in mice

Katsara, M., Day, S., Deraos, G., Tselios, T., Matsoukas, J. and Apostolopoulos, V. ImVacS - The immunotherapeutics and vaccine summit, Massachusetts, USA, August 2010. Towards a vaccine against Multiple Sclerosis

Nelson, K., Apostolopoulos, V., Day, S., Haines, C., Ashton, J. and Stojanovska, L. Asian Pacific Menopause Federation, Sydney, Australia, September 2010. The effect of Maca (Lepidium meyenii) on plasma blood glucose and cytokine patterns in postmenopausal Hong Kong Chinese women

Apostolopoulos, V. 5th Australian Health and Medical Research Congress, Melbourne, Australia, November 2010. Early breast cancer patients immunised with mannan-MUC1: 12 year followup

Mailins, L.R., Wilkinson, B., Day, S., Apostolopoulos, V. and Payne, R. Royal Australian Chemical Society Symposium, Sydney, NSW Australia, Febriuary 2011. Synthesis and biological evaluation of glycopeptides cancer vaccine candidates

Day, S., Wilkinson, B., Payne, R. and Apostolopoulos, V. Keystone Symposia – New Frontiers at the interface of immunity and glycobiology. Lake Louise, Alberta Canada, March 2011. Chemical synthesis and immunological evaluation of MUC1 glycopeptide tumour vaccine candidates

Katsara, M., Matsoukas, J. and Apostolopoulos, V. 12th International Conference Medicinal Chemistry: Drug Discovery and Design, University of Patras, Patras, Greece, April 2011. Therapeutic aspects for MS: are we heading in the right direction..?

Immunotherapeutic aspects for MS: are we heading in the right direction..

Kong, Y.Y., Fuchsberger, M., Apostolopoulos, V. and Plebanski, M. Australian Society of Immunology, Adelaide Australia, December 2011. Effects of cancer cells on the dendritic cell lineage

Asarat, M.O., Donkor, O.N., Apostolopoulos, V. and Vasiljevic, T. Australian Food Science Summer School, University of Melbourne, Australia, February 2012. Prebiotics fermentation and health significance of short chain fatty acids

Vassilaros, S., Tsibanis, A., Tsikkinis, A., Drakaki, E., McKenzie, I. and Apostolopoulos, V. San Antonio Breast Cancer Symposium, USA. December 2012. 13 year clinical follow-up of pilot phase III immunotherapy study in stage II breast cancer patients using oxidised mannan-MUC1

Perera, C.J., Zahrooni, S., Apostolopoulos, V. and Moalem-Taylor, G. Australian Neuroscience Society, Melbourne Australia. February 2013. Vaccination for neuropathic pain following peripheral nerve injury

Perera, C.J., Zahrooni, S., Apostolopoulos, V. and Moalem-Taylor, G. 4th International congress on neuropathic pain: The pain to relief starts with understanding. Toronto, Canada. May 2013. Immunisation with myelin-derived altered peptide ligands inhibits neuropathic pain following peripheral nerve injury

Katsara, M., Grigoriadis, N., Yuriev, E., Ramsland, P.A., Deraos, G., Matsoukas, J. and Apostolopoulos, V. Helani Congress of Neuroimmunology for Multiple Sclerosis, Athens, Greece, October 2013. Mannosylation of mutated MBP83-99 peptides diverts immune responses from Th1 to Th2 in SJL/J mice: Bioactive peptides for Multiple Sclerosis

​Apostolopoulos, V. 15th International Conference Medicinal Chemistry: Drug Discovery and Design, University of Patras, Patras, Greece, April 2014. Development of a breast and an ovarian cancer vaccine: what have we achieved in 20 years

Tseveleki, V., Tselios, T, Kanistras, I., Koutsoni, O., Friligou, I., Apostolopoulos, V., Dotsika, E., Matsoukas, J., Lassmann, H. and Probert, L. 15th International Conference Medicinal Chemistry: Drug Discovery and Design, University of Patras, Patras, Greece, April 2014.
Immunotherapy of experimental autoimmune encephalomyelitis using APC-targeted myelin peptides as prophylactic and therapeutic vaccines

Apostolopoulos, V. 5th Australasian vaccines and immunotherapeutics development (AVID) meeting. Burnet Institute, Melbourne VIC Australia, May 2014. Clinical study in stage II breast cancer patients using oxidised mannan-MUC1: clinical data 16.5 years on

Perera, C.J., Apostolopoulos, V. and Moalem-Taylor, G. 15th World Congress on Pain. International Association for the Study of Pain. Buenos Aires, Argentina, October 2014. Active immunisation with myelin basic protein and myelin-derived altered peptide ligand elicits differential effects on pain behaviours in normal and spinal cord-injured rats

1991, First ever Poster Presentation, Perth Australia
POSTERS - BEFORE TECHNOLOGY. cut and paste technology....!!
POSTERS - MODERN TECHNOLOGY....,!